The QualityStocks Daily Wednesday, February 17th, 2021

Today's Top 3 Investment Newsletters

Schaeffer's(CLPS) +121.22%

QualityStocks(BCII) +108.57%

Tip.us(LTTGF) +66.67%

The QualityStocks Daily Stock List

Arcadia Biosciences (RKDA)

StockMarketWatch, MarketClub Analysis, StreetInsider, Schaeffer's, BUYINS.NET, INO Market Report, QualityStocks, MarketBeat, ProTrading Research, Leading Penny Stocks, Planet Penny Stocks, Investing Futures, InvestorsUnderground, Marketbeat.com, OTCtipReporter, Penny Pick Finders, PennyStockScholar, TopPennyStockMovers, PoliticsAndMyPortfolio, Profitable Trader Authority, StockOnion, Today's Profits and PennyStockProphet reported earlier on Arcadia Biosciences (RKDA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Arcadia Biosciences Inc. (NASDAQ: RKDA) is an agricultural biotech firm that develops different traits to boost productivity in the crops that supply the world’s food markets. The company’s crop yield traits, which enhance both the nutritional value and quality of food ingredients and crops, are used by partners to develop seeds that are higher yielding for global crops such as soybean, wheat, rice, sugarcane and corn, in addition to other plants like trees, turf, cotton and hemp.

Arcadia Biosciences Inc. was founded in 2002 by John G. Sperling and Eric J. Rey and develops products which are either currently on the market or in advanced development stages. These products have different productivity traits, including herbicide tolerance, NUE (nitrogen use efficiency), ST (salinity tolerance), WUE (water use efficiency) and DT (drought tolerance). The company also produces sunflower oil.

The firm designs these productivity traits in a way that boosts the crops’ viability for industrial applications, the performance of crops in the field, as well as the crops’ value as wellness and health products and food ingredients. One of the company’s products is GoodHemp, which is made up of hemp seed varieties which are non-GMO and have been developed using the latest crop innovation tools, with the focus being to genetically improve hemp.

Arcadia Biosciences Inc. has partnerships with Bay State Milling Company, Ardent Mills, Arista Cereal Seeds Pty Ltd, Corteva AgriScience and LLC. The firm, which has over 50 products in development, recently announced that it had entered into agreements with several accredited and institutional investors to purchase its shares at an agreed price. Many predict that this sale will push the stock prices higher, which may bring good news both for shareholders in the company as well as its stakeholders.

Arcadia Biosciences (RKDA), closed Wednesday's trading session at $3.78, off by 5.50%, on 2,071,367 volume with 8,934 trades. The average volume for the last 3 months is 1,378,303 and the stock's 52-week low/high is $2.29999995/$6.40000009.

Blink Charging (BLNK)

MarketClub Analysis, InvestorPlace, StockMarketWatch, Schaeffer's, QualityStocks, MarketBeat, TradersPro, The Street, TraderPower, The Online Investor, Wealth Insider Alert, BUYINS.NET, PoliticsAndMyPortfolio, Wall Street Mover, TopPennyStockMovers, Trades Of The Day, InvestorsUnderground and StreetInsider reported earlier on Blink Charging (BLNK), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Blink Charging Co. (NASDAQ: BLNK, BLNKW) is an operator, provider and owner of networked electric vehicle charging services and electric vehicle charging equipment. The firm provides both commercial and residential electric vehicle charging equipment, which allows EV drivers to recharge their cars at different locations.

The company, which was founded in 1998 by Michael D. Farkas, was formerly known as Car Charging Group Inc. before legally changing its name in August 2017. The firm’s primary line of services and products are its electric vehicle supply equipment or electric vehicle charging equipment, the Blink Network and other electric vehicle related services.

The company’s Blink Network is a cloud-based software which tracks, maintains and operates all of the charging stations owned by the firm as well as any related charging data. The network also provides parking companies, managers and property owners with cloud-based services that allow for remote management and remote monitoring of payment processing and electric vehicle charging stations. In addition to this, the software provides electric vehicle drivers with charging station information.

Blink Charging Co. has its headquarters in Miami Beach, Florida. As of December 2020, the firm had over 23,000 stations across the United States. Recently, the firm sold common stock made up of 5,400,000 shares and plans to use the net proceeds to fund the deployment of more electric vehicle charging stations, as well as in the advancement of the company as a whole.

By acquiring complementary and competitive businesses and financing the advancement of various technologies and products, the company is looking at major growth in the near future, especially when one factors in the major shift to electric vehicles, as more people across the world push for green energy and more sustainable living.

Blink Charging (BLNK), closed Wednesday's trading session at $47.72, up 0.146905%, on 8,309,359 volume with 91,670 trades. The average volume for the last 3 months is 15,851,504 and the stock's 52-week low/high is $1.25/$64.50.

Molecular Data (MKD)

StreetInsider reported previously on Molecular Data (MKD), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Molecular Data Inc. (NASDAQ: MKD) operates a technology-driven platform in the chemical industry of China, which connects participants along the chemical value chain using integrated solutions. The firm uses a data-driven and SaaS-powered service platform to operate chemical e-commerce businesses in China, through its subsidiaries.

Molecular Data Inc. was founded in 2013 by Li Li and Dong Liang Chang and has its headquarters in Shanghai, the People’s Republic of China. The firm provides SaaS (software-as-a-service) suites that are meant to solve any issues participants in the chemical industry might come across.

Additionally, the firm generates all its revenues from China through chemical trading and sells chemical products to its consumers though either sales representatives or online platforms. Molecular Data Inc. also provides e-commerce solutions through its online platform that has been built on extensive artificial intelligence and knowledge engine capabilities. The platform consists of Chemical Community App, Moku Data Weixin account, molbase.cn and molbase.com.

The firm delivers logistics and warehousing solutions, financial solutions, and e-commerce solutions in China.

As of December 2020, the tech platform had appointed Steven Foo as the firm’s new Chief Financial Officer. With his extensive financial, asset management and analyst background, many believe Mr. Foo will usher Molecular Data Inc. into its next growth phase.

Molecular Data (MKD), closed Wednesday's trading session at $2.04, up 7.9365%, on 6,380,601 volume with 16,130 trades. The average volume for the last 3 months is 6,881,300 and the stock's 52-week low/high is $0.569999992/$3.8900001.

Tilray, Inc. (NASDAQ: TLRY)

InvestorPlace, Schaeffer's, The Street, MarketBeat, MarketClub Analysis, Trades Of The Day, StocksEarning, StockMarketWatch, StreetInsider, Daily Trade Alert, Wealth Insider Alert, Market Intelligence Center Alert, The Online Investor, BUYINS.NET, Investopedia, Zacks, CFN Media Group, StreetAuthority Daily, Daily Profit, CNBC Breaking News, Kiplinger Today, The Street Report, StockEarnings, QualityStocks, Inside Trading, InvestmentHouse, Trading Concepts, The Rich Investor and Trading For Keeps reported beforehand on Tilray, Inc. (TLRY), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

Tilray, Inc. (NASDAQ: TLRY) is a pharmaceutical firm that is engaged in research, growing, production and distribution of cannabinoids, recreational and medical marijuana. The firm operates through its Hemp and Cannabis Segments.

The firm’s Hemp segment sales are made up of broad spectrum hemp extract that contains CBD, hemp food and hemp seed, which are sold directly to consumers, or to wholesalers and retailers, in unlicensed operations. On the other hand, its Cannabis segment sales are made up of medical, adult-use and huge sales of marijuana under regulated licenses, which are sold directly to patients as well as to governments, pharmacies, wholesalers and retailers. The firm also provides its products to researchers for commercial purposes, as well as for clinical research applications and compassionate access.

Tilray was founded on January 24 in 2018 and is based in Nanaimo, Canada. The firm operates in other countries apart from Canada, including the United Kingdom, Argentina, the U.S., Australia, Switzerland, Chile, South Africa, Portugal, Croatia, New Zealand, Cyprus, Ireland, the Czech Republic, Israel and Germany.

Tilray develops marijuana based medicines, drops, dried marijuana and marijuana extracts, as well as oil products. The firm sells these products through various brands under it, including Manitoba Harvest, Dubon and Canaca. The firm’s subsidiary - FHF Holdings Ltd, also markets, manufactures and distributes consumer products that are hemp-based. Apart from a partnership with AB InBev to develop marijuana-infused drinks, the company recently announced that it would be merging with Aphria Inc., another Canadian cannabis firm.

Many anticipate that this merger may broaden both companies’ hold on the cannabis market, as this merger may make them one of the largest firms globally. Their combined range, from Tilray’s Portugal facility to Aphria’s CC Pharma asset in Germany, may also provide both firms with a competitive edge in the budding marijuana market.

Tilray, Inc. (TLRY), closed Wednesday's trading session at $31.51, off by 9.0095%, on 40,167,489 volume with 276,220 trades. The average volume for the last 3 months is 39,726,929 and the stock's 52-week low/high is $2.43000006/$67.00.

Moovly Media, Inc. (MVVYF)

We reported earlier on Moovly Media, Inc. (MVVYF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Moovly Media, Inc. is a leading content blending enterprise with a suite of products and services for video content creation. The Company’s vision is to become the number 1 platform for engaging, customizable multimedia content creation. Its mission is to enable all to create engaging multimedia content through making it affordable, intuitive, and also simple. The Company is positioned to be a value adding partner in the Content Players, Video Aggregators, and Agencies industries. Moovly Media is based in Vancouver, British Columbia.

The Company is the technology leading provider of cloud based tools to produce marketing, communications, and training videos and presentations. Its advanced Studio editor with greater than 100M digital assets seamlessly integrated (via partnership with Getty Image and others), provides all one needs in one simple to use “drag and drop” editor. Moovly Media’s API and Automator API technology allow it and 3rd parties to automate some or all of the process of creating content. This is whether that be mass customized, individually personalized (Video version of MailMerge), automatic content creation, or updating by connecting data sources. With Moovly’s technology one picks a video template or starts from scratch. They then drag, drop and animate. Next, they export and share their video.

Moovly Automators/API is a rich API and tool kit to enable semi and fully automated content creation. It features automated mass conversion of images, text, and other media into videos. In addition, it features mass capture and auto branding and formatting of testimonials, and engaging consumer campaigns for brands and agencies. Also, Moovly Automators/API features user or data based driven mass customization of videos (MailMerge for Video). The Company also has its iOS and Android Mobile App.

Moovly Studio is an advanced online video editor with digital assets included - sounds, videos, and images. Their is no software to download and maintain. It features a Future Proof editor based on HTML5 technology. There are more than 100 Million video clips, sounds, and images included in the platform. Moreover, Moovly Studio features a Mobile App to manage, upload, and display content. It has advanced API for easy integration with authentication and third party applications.

Moovly Media previously announced that it extended its European Government Contract for three years. Moovly announced that, because of excellent uptake by this government agency client, it secured a three-year enterprise subscription extension and expansion. The client has extended their subscription with Moovly Media for a further 3 years in a deal worth an estimated CA$150,000. The client has successfully deployed Moovly within its organization, with hundreds of users making thousands of videos with Moovly.

Recently, Moovly Media announced that it enhanced its existing cloud-based video content creation platform by launching a new live video communications service called the Moovly Video Collaborator (MVC). The MVC is a live video communication tool. It allows several users to interact in real time, offering Moovly group subscribers a live video communication tool for collaboration that is seamlessly integrated into the existing Moovly platform. The MVC includes features such as screen sharing, chat, and a host of additional options making it easier for Moovly groups to communicate in real time.

Moovly Media, Inc. (MVVYF), closed Wednesday's trading session at $0.6593, up 34.8372%, on 3,380,816 volume with 1,058 trades. The average volume for the last 3 months is 406,117 and the stock's 52-week low/high is $0.0195/$0.709999978.

Sunstock, Inc. (SSOK)

QualityStocks, Stockgoodies, SizzlingStockPicks, Pennystockmania, POSstocks, Penny Stock Mobsters, WallstreetSurfers, Stock Commander, Journal Transcript, Winning Stock Plays, PennyStock Tweets, Damn Good Penny Picks, OTCtipReporter, Penny Pick Finders, Penny Picks, Buzz Stocks, Planet Penny Stocks, Profitable Trader Authority, StockOnion and PennyStockProphet reported  previously on Sunstock, Inc. (SSOK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Sunstock, Inc. operates a coin store that buys and sells precious metal coins and also an asset-backed set of cryptocurrencies backed by gold, silver, and platinum. It operates one precious metals retail store under Mom’s Silver Shop in Sacramento, California. Sunstock pursues a “ground to coin” strategy. Thus, it secures and/or acquires mining assets and also rights to purchase mining production, and sells these metals mainly through retail channels through their own branded coins. Formed in 2012, Sunstock is headquartered in Sacramento, California.

Sunstock is moving ahead with “Triple 8”, precious metal asset-backed Crypto Tokens. The Company is redefining how the world conceptualizes and uses money with the pending launch of asset-backed cryptocurrencies, which are directly tied to the value of gold bullion. “Triple 8” provides a value proposition for investors and end-users of the token.

Sunstock’s plan is to become a pure gold play stock, with plans to own a complete Vertical Integration in the gold industry. Its intention is to acquire mineral rights and gold mining assets to complement its robust and growing gold distribution business. The Company anticipates acquisition prices in the $5,000,000 to $10,000,000 range. The mines it is considering are producing upwards of 60,000 ounces of gold annually.

Sunstock states that it is in talks to acquire or partnership with a number of assets that could potentially produce billions in revenue over 5-10 years. The Company is centered on projects that already own substantial amounts of unrefined – but already mined – gold ore.

Mr. Jason Chang is the Founder, Chairman, Chief Executive Officer and Investor Relations Officer of Sunstock, Inc. Mr. Chang has more than 20 years of hospitality management experience. He began his career in the hospitality industry in the family business operating several hotels throughout California.

This week, Sunstock announced that it added to its existing precious metals sales and distribution strategy by targeting acquisitions in the gold mining industry. At the same time, It is working with its partners and advisors on a strategy to uplist to the OTC Markets Group’s OTCQB.

Sunstock, Inc. (SSOK), closed Wednesday's trading session at $0.0086, up 53.5714%, on 135,462,197 volume with 2,067 trades. The average volume for the last 3 months is 50,917,229 and the stock's 52-week low/high is $0.000799999/$0.0215.

Loans4Less.com, Inc. (LFLS)

QualityStocks, Tip.us, FeedBlitz, PennyStocks24, AheadoftheBulls.com, Penny Stock Pulse, 24-7 Stock Alert, Penny Stock Explosion, PremiereStockAlerts, SeriousTraders, Penny Stock Rumble, SmallCapVoice, OTC Picks, MyBestStockAlerts, INO.com Market Report, Greenbackers, Stocknewscast.com, ChartPoppers, Street Beat and Penny Stock Racer reported previously on Loans4Less.com, Inc. (LFLS), and today we report on the Company, here at the QualityStocks Daily Newsletter. 

Loans4Less.com, Inc. is a State of California online Mortgage Broker for conforming residential mortgages. The Company features very competitive rates, terms and costs, daily rate updates, as well as other market information. Headquartered in Torrance, California, Loans4Less.com does not operate a warehouse line of credit, hold trust funds, lend directly or service loans. The Company’s shares trade on the OTC Markets.

Loans4Less.com relies on different wholesale lenders for its retail home loan programs. It looks to engage a strategic partner to broaden the Loans4Less generic Federal Service Mark to maximize its shareholders value. Since 1993, it has successfully helped its clients close on excellent rates.

Loans4Less.com’s aim is to offer the lowest deliverable rates and closing costs. The Company offers premier guidance and service to all borrowers. It does not quote rates and/or points that are not deliverable. Loans4Less cannot provide Borrowers with below market non-deliverable interest rates, points and/or closing costs. The Company does not practice inducement tactics by posting at its website unrealistic quotes.

In addition, Loans4Less.com does not sell or pass on a client’s confidential information to any third party. The Company cannot register their loan or order their credit factual report without an executed Borrower's Certification and Authorization Form and six key items comprising of the Application.

Loans4Less.com owns Union Discount Mortgage, Inc. This is a licensed CA Real Estate Corporation and Mortgage Broker. Union Discount Mortgage controls the rights to certain intellectual property (IP). This includes, but is not limited to, the Loans4Less.com web site and the Loans4Less® Federal Service Mark. The Loans4Less.com and Loans4Less® service mark are used to advertise Union Discount Mortagage, Inc. as a Mortgage Broker and not as a Lender.

Mr. Steven M. Hershman is the President, Treasurer, Chief Financial Officer, and Chairman of the Board of Loans4Less.com, Inc. Mr. Hershman has devoted his efforts to Loans4Less.com as a Mortgage Broker. He holds a California Real Estate Broker License. In 1990, Mr. Hershman became a mortgage broker and he established Union Discount Mortgage, Inc. in April of 1993.

Loans4Less.com, Inc. (LFLS), closed Wednesday's trading session at $0.0898, even for the day, on 16 volume. The average volume for the last 3 months is 10,545 and the stock's 52-week low/high is $0.010999999/$0.147699996.

Almonty Industries, Inc. (ALMTF)

We reported previously on Almonty Industries, Inc. (ALMTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Almonty Industries, Inc. focuses on the mining, processing, and shipping of tungsten concentrate from its Los Santos mine in western Spain and its Panasqueira mine in Portugal. The Company also focuses on the development of its Sangdong tungsten mine in Gangwon Province, South Korea, and the development of the Valtreixal tin/tungsten project in northwestern Spain. Almonty Industries has its head office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQX.

In September of 2011, the Los Santos mine was acquired by Almonty Industries. It is positioned roughly 50 kilometers from Salamanca in western Spain and produces tungsten concentrate.

The Panasqueira mine has been in production since 1896. It is situated roughly 260 kilometers northeast of Lisbon, Portugal. It was acquired in January of 2016 and produces tungsten concentrate.

In September 2015, the Sangdong mine was acquired via the acquisition of a 100 percent interest in Woulfe Mining Corp. Almonty Industries owns 100 percent of the Valtreixal tin-tungsten project in northwestern Spain.

Previously, Almonty Industries announced that it signed a Power Supply and Consumption Agreement with Korea Electric Power Corporation (KEPCO) for the construction and supply of a power line to the Sangdong Tungsten Mine situated in the Republic of Korea. The Power Supply and Consumption Agreement between Almonty Korea Tungsten Corp. (AKTC), a wholly-owned subsidiary of Almonty Industries, and KEPCO, a state-owned monopoly power supplier, is for the construction and installation of a 10MW exclusive power line to the site of the Sangdong Mine. Under the Power Supply & Consumption Agreement, KEPCO is responsible for constructing the high voltage power line (22.9kV) of 22.8 km and auxiliary facilities connecting the Taebaek Sub-station of KEPCO and the transfer point designated inside the Sangdong Mine site.

Almonty Industries, Inc. (ALMTF), closed Wednesday's trading session at $0.8782, up 43.9672%, on 2,366,851 volume with 1,567 trades. The average volume for the last 3 months is 14,170 and the stock's 52-week low/high is $0.236100003/$0.89499998.

Meso Numismatics, Inc. (MSSV)

We reported previously on Meso Numismatics, Inc. (MSSV), and today we choose to report on the Company once again, here at the QualityStocks Daily Newsletter. 

Meso Numismatics, Inc. is a technology and numismatic company specializing in the Meso Region, including Central America and the Caribbean. It has become the primary hub for rare, exquisite, and valuable inventory from the Meso Region and worldwide. The Company was previously known as Pure Hospitality Solutions, Inc. It changed its name to Meso Numismatics, Inc. as a result of its merger with Meso Numismatics, Corp. in September of 2018. Meso Numismatics has its head office in Boca Raton, Florida.

Meso Numismatics is the only Company in the Central American-Caribbean region that is an on-the-ground registered dealer with the Numismatic Guaranty Company (NGC) and the Paper Money Guaranty (PMG). The Company has a selection of rare inventory, and also has a specialized App for banknote recognition, available on Google Play and the Apple App Store. Meso continues to partner with some of the largest auction houses internationally for the sale of the Company’s rarer inventory.

Meso Numismatics was established in September 2016 by a group of devoted coin collectors and currency seekers from the Mesoamerica area - from Mexico to Panama. The Company specializes in this area of the region. Moreover, Meso also has inventory and clients from all over the world. Numismatics is the study or collection of currency. This includes coins, tokens, paper money, as well as related objects.

In September, Meso Numismatics announced that it has preliminarily completed the due diligence phase of the Green Pay acquisition and is now set to proceed with an audit of Green Pay to be performed by the Company’s independent registered accounting firm. According to Management, Meso’s counsel will soon begin preparing the definitive purchase agreement for the Green Pay acquisition.

Afterward, the expectation is that Meso Numismatics will issue shares of its Preferred Stock as an initial payment for the acquisition. Following that, its U.S. independent registered accounting firm will start to audit Green Pay’s financials, preparing them to be included in Meso’s SEC filings at some later date.

At present, Green Pay hosts 110 independent stores located around Central America; processes around $2.5M in monthly transactions among all of its users; and executes roughly 500,000 transactions per month. Green Pay also has approximately 400,000 monthly active users; and has about 650,000 registered credit cards representing multiple payment institutions around Central America.  

Meso Numismatics, Inc. (MSSV), closed Wednesday's trading session at $0.1595, up 85.0348%, on 892,066 volume with 69 trades. The average volume for the last 3 months is 66,618 and the stock's 52-week low/high is $0.007199999/$0.166899994.

Blockchain Industries, Inc. (BCII)

TopPennyStockMovers reported beforehand on Blockchain Industries, Inc. (BCII), and today we highlight the Company again, here at the QualityStocks Daily Newsletter.

Blockchain Industries, Inc. is a merchant bank focused on the global blockchain and cryptocurrency sectors. It consists of a Blockchain Technology Advisory, an Investment Management arm, and a Global Conference Series (Blockchain Unbound) connecting entrepreneurs and investors. The Company previously went by the name Omni Global Technologies, Inc. It changed its name to Blockchain Industries, Inc. in November of 2017. Blockchain Industries is headquartered in Santa Monica, California.

The Company’s corporate mission is to make Blockchain Technology accessible, transparent and compliant. Blockchain Industries concentrates on long-term results - in innovation that can help governments streamline their processes, rebuild struggling economies, transform legislative practices, revolutionize healthcare and education, and ultimately better humanity.

Blockchain Industries offers early access to coveted protocols and token issuances, and considerable technical competence, an extensive industry network, and a recognized global brand. In addition, it offers top-tier experiences in finance and operations with an emphasis on compliance and risk management.

The Company’s intention is to offer investment management for blockchain-related assets; and blockchain advisory services. This includes architecting token structure and issuance, crypto-economic design, technology/engineering, consulting, generating whitepapers, software development, and marketing. Additionally, its intention is to invest in, partner with, or acquire media streams, news outlets, or other content distribution methods centered on the marketing of blockchain technologies and Digital Asset economies; partner with educational institutions to train blockchain developers; and set up cryptocurrency mining facilities.

Recently, GoChain announced it has partnered with IriSafe, Inc. and Blockchain Industries to develop blockchain-based identity management solutions. IriSafe is a Singapore-based joint venture (JV) between IriTech and Blockchain Industries. With guidance from Blockchain Industries, GoChain and IriSafe entered a binding joint development agreement.

GoChain will take advantage of IriTech's biometrics hardware and software development kits in collaboration with IriSafe to provide the world's first blockchain identity management solutions using ultra-secure, government-tested and certified iris-scanning technology. These solutions will be constructed on GoChain's best-performing public web3-based network, giving users quicker transaction speeds and enterprise-level support that are not available with traditional identity management solutions.

Blockchain Industries, Inc. (BCII), closed Wednesday's trading session at $1.46, up 108.5714%, on 1,138,398 volume with 1,307 trades. The average volume for the last 3 months is 397,977 and the stock's 52-week low/high is $0.0722/$9.00.

Powerbridge Technologies Co., Ltd. (PBTS)

StockMarketWatch, QualityStocks, MarketBeat and StreetInsider reported beforehand on Powerbridge Technologies Co., Ltd. (PBTS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Powerbridge Technologies Co., Ltd. is a worldwide trade software application and technology services provider. The Company is a provider of software application and technology solutions and services to corporate and government customers mainly located in China. Established in 1997, Powerbridge Technologies pioneered worldwide trade software applications with a vision to make global trade operations easier for customers. Powerbridge Technologies has its corporate headquarters in Zhuhai, China.

Powerbridge Technologies offers Powerbridge System Solutions that include Trade Enterprise and Trade Compliance, and also Import & Export Loan and Insurance Processing for customers to streamline their trade operations, trade logistics, and regulatory compliance. In addition, the Company provides Powerbridge Software-as-a-Service solutions that include Logistics Service Cloud and Trade Zone Operations Cloud, and also Inward Processed Manufacturing Cloud, Cross-Border eCommerce Cloud, and Import & Export Loan and Insurance Processing Service Cloud.

Powerbridge System Solutions and Powerbridge Saas Services feature comprehensive and strong customized solutions and packaged products. These allow customers to streamline and optimize operations in regulatory compliance, trade logistics and trade financing. The Company’s solutions and services have been deployed and used by thousands of corporate and government customers engaged in international trade. Powerbridge sells its solutions and services by way of its direct sales organization, indirect channel partners, and strategic government partners.

Powerbridge Technologies Co., Ltd. (PBTS), closed Wednesday's trading session at $6.38, up 62.341%, on 9,989,505 volume with 47,080 trades. The average volume for the last 3 months is 122,524 and the stock's 52-week low/high is $1.75/$9.64999961.

Exactus, Inc. (EXDI)

QualityStocks, MarketBeat, Wall Street Mover, TopPennyStockMovers, SeeThruEquity Research, PoliticsAndMyPortfolio and InvestorPlace are reporting on Exactus, Inc. (EXDI), here at the QualityStocks Daily Newsletter.

OTCQB-listed, Exactus, Inc. is a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products. In addition, the Company is developing point of care diagnostics. Exactus sells its CBD products direct to consumers by way of its Hemp Healthy® brand. It also sells white label products to third-party resellers. Exactus has its corporate office in Delray Beach, Florida.

Furthermore, Exactus engages in producing industrial hemp from farms in Oregon. Its plan is to extract and manufacture directly through cGMP facilities. Exactus One World is the name of the Exactus farming and production initiative.

With the acquisition of Hemp Healthy, Exactus’ plan is to introduce and launch additional CBD products this year. The Company states that Hemp Healthy will continue to serve as an information resource and leader in the CBD market place through setting the industry standards on transparency and quality with every product. Moreover, the Hemp Healthy platform also offers a sales affiliate program for medical professionals and social influencers.

Exactus previously entered into a Master Product Development and Supply Agreement with Ceed2Med. Ceed2Med utilizes cGMP facilities and with the Agreement, Exactus has been allotted a minimum of 50 and up to 300 kilograms per month, and up to 2,500 kilograms annually, of active phyto-cannabinoid (CBD) rich ingredients for resale. Exactus offers tinctures, edibles, capsules, and topical solution products manufactured for use by Ceed2Med. Ceed2Med is a worldwide sourcing and distribution platform for industrial hemp and industrial hemp-derived products.

Recently, Exactus announced it appointed Mr. Emiliano Aloi as President. Before his appointment to President, Mr. Aloi has served as a member of the Exactus Advisory Board. Prior to joining Exactus, he began working in the hemp industry in 2014 in Uruguay, where he achieved the first nation-wide agricultural permit for flower cultivation in 2016. In 2018, he co-founded Ceed2Med, LLC.

Exactus, Inc. (EXDI), closed Wednesday's trading session at $0.248, up 30.5263%, on 592,306 volume with 53 trades. The average volume for the last 3 months is 120,976 and the stock's 52-week low/high is $0.039999999/$0.332899987.

Blue Line Protection Group, Inc. (BLPG)

QualityStocks, Cannabis Financial Network News, Penny Stock Hub, DSR News, Elite Stock Alerts, BestDamnPennyStocks, Journal Transcript, TheNextBigTrade, TheTradingReport, Shiznit Stocks, SmallCapGrowth, InvestorPlace, GrowthPennyStocks, SmallCapVoice, StockRunway, CFN Media Group and Penny Stock General reported previously on Blue Line Protection Group, Inc. (BLPG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Blue Line Protection Group, Inc. provides consulting, armed security, compliance and investigations, transportation, and secure vaulting services to banks, businesses and government entities. The Company’s professional team consists chiefly of former military and law enforcement personnel with decades of experience in protection, investigations, logistics, and tactical industries. Blue Line Protection Group is based in Denver, Colorado and lists on the OTC Markets.

The Company works side-by-side with retail establishments. It lessens the risk of criminal activity and creates a secure retail experience through protecting businesses on-site and securing their assets on the road.

Blue Line helps retailers remain compliant with all applicable laws. Furthermore, it shows retail establishments how to protect their businesses through letting Blue Line assume the responsibility and liability for their protective services.

The Company serves banks and credit unions through providing currency processing and transportation solutions. Its risk mitigation services help financial institutions serving cash-intensive industries comply with federal “know your customer” mandates. Blue Line Protection Group announced in October of 2018 that its Cash In Transit (CIT) operations, including vaulting, processing, and tactical compliance, is now available in Arizona.

Blue Line acts on behalf of banks and credit unions through collecting cash sales revenue from their client locations. Upon collecting the currency, the Company transports it to one of its secure processing facilities. Blue Line provides currency handling and validation services for the bank and transportation of processed currency to the Federal Reserve.

Blue Line Protection Group and Hypur have plans to open a cash vaulting and processing facility. This is to serve marijuana-related businesses (MRBs) and cash-intensive businesses (CIBs) in Nevada. Blue Line plans to partner with Hypur to expand services to Arizona, Oregon, Washington, California and Nevada. Hypur is a financial technology company based in Scottsdale, Arizona. The new Nevada facility will implement “Hypur Vault” cash management technologies.

Blue Line Protection Group’s Professional Affiliations include National Cannabis Industry Association, ASIS International, Marijuana Industry Group, Society of Corporate Compliance and Ethics, and Marijuana Business Association. Its Professional Affiliations also include International Association of Chiefs of Police, Professional Private Investigators Assn of Colorado, and Society for Human Resources Management.

Blue Line Protection Group, Inc. (BLPG), closed Wednesday's trading session at $0.0164, up 30.1587%, on 27,388,931 volume with 621 trades. The average volume for the last 3 months is 35,419,382 and the stock's 52-week low/high is $0.000199999/$0.0185.

Endo International plc (NASDAQ: ENDP)

MarketClub Analysis, StocksEarning, Schaeffer's, The Street, StreetInsider, MarketBeat, Barchart, Marketbeat.com, Zacks, Buttonwood Research, SmarTrend Newsletters, BUYINS.NET, InvestorsUnderground, StockMarketWatch, Daily Trade Alert, Daily Markets, StreetAuthority Daily, Trades Of The Day, INO.com Market Report, Investors Alley, AllPennyStocks, MarketWatch, TopStockAnalysts, The Weekly Options Trader, Louis Navellier, Greenbackers, Wyatt Investment Research, The Street Report, TradingMarkets, Investors Underground, InvestorPlace, QualityStocks, Investing Futures, SmallCap Network, SmallCapNetwork, SmallCapVoice, TraderPower, Investopedia, Daily Profit, Dynamic Wealth Report and Street Insider reported previously on Endo International plc (ENDP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Endo International plc (NASDAQ: ENDP) traded at a new 52-week high today of $9.88. Approximately 1.2 million shares have changed hands today, as compared to an average 30-day volume of 4.5 million shares.

In the past 52 weeks, Endo International plc share prices are bracketed by a low of $2.08 and a high of $9.88 and is now at $9.57, 360% above that low price.

Potential upside of 156.0% exists for Endo International plc, based on a current level of $9.57 and analysts' average consensus price target of $24.50.

After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence in pain management. The acquisitions of Auxilium and Par increased the company's presence in urology and generics, respectively.

Endo International plc (ENDP), closed Wednesday's trading session at $10.02, up 7.5107%, on 4,450,107 volume with 19,860 trades. The average volume for the last 3 months is 4,152,978 and the stock's 52-week low/high is $2.07999992/$10.2600002.

The QualityStocks Company Corner

Mohawk Group Holdings Inc. (NASDAQ: MWK)

The QualityStocks Daily Newsletter would like to spotlight Mohawk Group Holdings Inc. (MWK).

Mohawk Group Holdings (NASDAQ: MWK), a growing tech-enabled consumer products company, has continued its quest to become the leading e-commerce consumer brands platform with its latest acquisition of Healing Solutions, LLC. MWK paid approximately $15.3 million in cash in addition to issuing approximately 1.4 million shares of Mohawk’s common stock. On its own, MWK has launched consumer products across four brands, spanning home and kitchen, beauty, consumer electronics, and appliances. Thus, the acquisition heralded its entry into the essential oils’ category. Also today, the company was highlighted by InvestorBrandNetwork as MWK traded at a new 52-week high today of $48.19. Approximately 249,000 shares have changed hands today, as compared to an average 30-day volume of 952,000 shares.

Mohawk Group Holdings Inc. (MWK) is a leading tech-enabled consumer products platform that uses machine learning, natural language processing and data analytics to design, develop, market, and sell products. The company’s proprietary AIMEE(R) platform leverages data and AI to automate the design, development and launch of best-selling consumer products.

Mohawk owns and operates 12 brands and sells consumer products in multiple categories ranging from kitchenware and home appliances to environmental appliances, beauty products and even consumer electronics.

Founded in 2014, Mohawk has offices in the United States, Canada, China and the Philippines. The company is always working to capitalize on the strength of the different cities and time zones in which it operates to ensure continued excellence around the world and achieve its goal of becoming the most consumer-centric product company.

AIMEE(R) Platform

AIMEE(R) (AI Mohawk E-commerce Engine) is Mohawk’s proprietary platform that leverages data and AI to:

  • Identify new market opportunities;
  • Launch new products;
  • Automate marketing variables; and
  • Analyze and optimize company-owned and operated consumer product brands.

The platform’s core functionalities include:

  • Research: Automated research using live market data that tracks exposure and product trends, allowing for the swift discovery of new market and product opportunities;
  • Financials: Places data insights in one place, enabling execution across multiple channels to track new product planning, financial projections, inventory levels, media buying and more;
  • Trading: The result of an algorithmic solution that has been optimized for live decisions to scale sales and built to implement automated marketing strategies with learning through experimentation; and
  • Logistics: Manages logistics to enable faster delivery of products to consumers.

Mohawk’s Business Model

Mohawk’s unique business model is designed to drastically shorten go-to-market time, decreasing the typical 18- to 24-month process to just 6- to 8-months. Using AIMEE(R), Mohawk leverages real-time data-driven opportunities and trend tracking to replace the idea focus group research and development of the standard model.

Marketing time is also reduced between the two models using the AIMEE(R) Trading Engine for data-driven automated marketing and product lifetime management. Through the AIMEE(R) trading engine, the traditional 3-month marketing for a standard go-to-market model is cut to a fraction of the time.

The AIMEE(R) Fulfillment Engine allows for dynamic inventory allocation, fulfillment selection, cost optimization, a third-party logistics network and a 2-day shipping period across almost all of the United States. The standard business model doesn’t support direct distribution or an FBA (fulfilled by Amazon) structure.

Opportunities for Growth and Profitability

Mohawk’s plan to drive growth and profitability in the market includes:

  1. The continued optimization of product economics by lowering manufacturing and logistical costs through an increase in purchasing power
  2. The pursuit of higher-value products with larger target markets
  3. Opportunistically adding new products and categories through acquisitions
  4. Expansion into the international and new domestic e-commerce marketplaces
  5. Monetization of its proprietary AIMEE(R) platform by providing access to third-party brands

Mohawk’s long-term goal is to increase its profit margin from 14% in 2020 to 18-20%, using higher average selling prices and lower fulfillment costs as primary drivers. Due to its technology and platform effect, Mohawk’s corporate overhead is expected to increase at a slower pace than sales. Its fixed operating costs long-term target goal is 5%, which follows the current trend (2019 – 19%, 2020 – 13%). It aims for an adjusted EBITDA of 13-15%.

Management Team

Yaniv Sarig has been Mohawk’s President and Chief Executive Officer since September 2018. He is also a co-founder of Mohawk Group Inc. Mr. Sarig has served as the President and Chief Executive Officer of Mohawk Group Inc. since June 2014. Before his role at Mohawk, he led the Financial Services Engineering department at Coverity, a software startup providing code and security solutions to top financial institutions and hedge funds in New York to include the New York Stock Exchange, Nasdaq, JPMorgan Chase and Barclays. Before his Coverity role, Mr. Sarig held lead technical roles at Bloomberg and EPIQ Systems Inc. (NASDAQ: EPIQ). He holds a Bachelor of Science from Touro College. He is fluent in English, French, Hebrew and C++.

Fabrice Hamaide has been the Chief Financial Officer of Mohawk since September 2018. He has also retained the position of Chief Financial Officer for Mohawk Group Inc. since July 2017. Before Mohawk, Mr. Hamaide held numerous financial, CFO and presidential roles in various technological and consumer product companies across Europe and the United States, including Piksel Inc., Atari, Parrot and Logitech. Mr. Hamaide holds an impressive set of credentials, including an MBA from Columbia Business School, an MS in Information Systems Design from Sorbonne University, and a BS in Applied Mathematics from Jussieu University.

Mihal Chaouat-Fix has been the Chief Product Officer for Mohawk since September 2018. Prior to taking this role within the company, she was the Chief Operating Officer, handling the day-to-day leadership and operational management of Mohawk. Before joining Mohawk, Ms. Chaouat-Fix worked in various roles at Gottex Models Ltd. At this international fashion swimwear firm, her focus on marketing, operations and manufacturing saw supply chain and distribution of 12 million units per year to over 40 countries worldwide.

Tomer Pascal has been the Chief Revenue Officer for Mohawk since 2018. He has also served as the Chief Revenue Officer for Mohawk Group Inc. since 2017. Before he joined the Mohawk team, he was the Chief Executive Officer and co-founder of OMG Studios. Throughout his career, Mr. Pascal has held many different co-founder and general management roles, focusing on companies’ marketing and revenue growth in the media and technology industries.

Roi Zahut has held the role of Chief Technology Officer for Mohawk since 2019. Before Mohawk, he served in numerous roles, including CTO of the Advanced Analytics global consulting team at IBM and architect of IBM Metropulse. While in Israel, Mr. Zahut held several senior technical, business and data science roles in startups and consulting to include IBM Israel, Brainbow Ltd. and Matrix IT Ltd. He holds an MSc in Neuroscience with distinction from Bar Ilan University.

Mohawk Group Holdings Inc. (MWK), closed Wednesday's trading session at $47.66, up 0.273511%, on 1,185,330 volume with 12,560 trades. The average volume for the last 3 months is 727,796 and the stock's 52-week low/high is $1.41999995/$48.9900016.

Recent News

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element (NASDAQ: NETE) was featured today in a publication from Green Car Stocks, examining how Joe Biden’s first few weeks in office have seen him issue a flurry of executive orders, some that will set the tone for the rest of his presidency. An ambitious plan by the President to help battle climate change would see 500,000 electric vehicle (“EV”) charging stations deployed across the United States by 2030. Via executive order, Biden says he will also replace the U.S. government’s fleet of nearly 650,000 cars with electric models.

On June 15, 2020, Net Element announced its entry into a binding letter of intent to merge with privately-held Mullen Technologies Inc., a Southern California-based electric vehicle company, in a stock-for-stock reverse merger in which Mullen’s stockholders will receive the majority of the outstanding stock in the post-merger company. The proposed merger is currently pending the execution of a definitive agreement, shareholder vote and regulatory approval.

Net Element Inc. (NASDAQ: NETE) is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce and mobile devices. The company operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. The company’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element chairman and CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked on Deloitte’s Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in both 2017 and 2018, during which the company grew 190 percent and 183 percent, respectively. The company credits its progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

Net Element was also listed among South Florida Business Journal’s 2016 fastest growing technology companies.

Leveraging its suite of application performing interfaces (APIs) and connectors, Net Element powers commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Leading this innovation is chairman and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations like Aptito to e-commerce and retail payment transaction processing brands like Payonline and Unified Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed Wednesday's trading session at $15.36, up 9.2461%, on 826,146 volume with 4,253 trades. The average volume for the last 3 months is 2,286,785 and the stock's 52-week low/high is $1.472/$20.0783996.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX Inc was highlighted by InvestorBrandNetwork as shares traded today at $7.10, eclipsing its 52-week high. So far today approximately 365,000 shares have been exchanged, as compared to an average 30-day volume of 930,000 shares.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday's trading session at $6.50, up 4.3339%, on 1,855,711 volume with 6,486 trades. The average volume for the last 3 months is 522,711 and the stock's 52-week low/high is $1.50999999/$7.19500017.

Recent News

HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF)

The QualityStocks Daily Newsletter would like to spotlight HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF).

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that Mount Sinai Medical Hospital, New York City, has selected HempFusion CBD as the exclusive brand and the sole supplier in a six-month clinical trial. Dr. David Harnick, a board-certified cardiologist and electrophysiologist and assistant professor in medicine and cardiology at Mount Sinai, is conducting the trial comprised of two studies that is one of the first of its kind in the area of CBD’s effect on targeted cardiology markers. To view the full press release, visit: https://cnw.fm/wrogo. Also today, the company was highlighted in a publication from FN Media Group, examining how, as public acceptance and use continues to grow, so too does the positive momentum in opening of new markets for the cannabis derivative CBD. A new bipartisan bill is currently being reintroduced to the US congress , while the European CBD market is already projected to grow 400% through 2023.

HempFusion Wellness Inc. (TSX: CBD.U) (FWB: 8OO) (OTC: CBDHF) is a leader in the health and wellness CBD industry, providing innovative and diversified proprietary formulations utilizing the power of whole-food hemp nutrition.

Invested heavily in regulatory compliance, HempFusion aims to consistently meet and even exceed the high standards required by retailers and consumers – putting safety, quality and consistency first. In support of these efforts, the company is U.S. Hemp Authority Certified and is a current board member of the U.S. Hemp Roundtable, a coalition of leading companies committed to advancing safe hemp and CBD products.

HempFusion reported 1,750 shareholders and $18.3 million in cash as of June 30, 2020 – the second-largest cash position in its sector – with no debt. Looking ahead, the company is currently preparing to launch an IPO directly onto the Toronto Stock Exchange (“TSX”) senior board, where it has already reserved ticker symbol ‘CBD.U’. Learn More About HempFusion Upcoming IPO.

HempFusion is headquartered in Denver, Colorado.

HempFusion’s Proprietary Wellness Portfolio

The diverse product portfolio showcased by HempFusion includes 46 products that are currently on shelves. The company’s leading offerings include HempFusion-owned Biome Labs, HF Labs and Probulin. Due to the time and resources allocated to increasing the compliance of these proprietary products, HempFusion may have a competitive advantage and create additional retail opportunities that are not available for other CBD companies.

HempFusion’s Diversified Revenue Pipeline

HempFusion’s focus and investment into regulatory compliance has opened doors to major food and drug mass or big box retailers that are not available to other CBD companies. This strategic approach includes five distinct channels:

  • Natural Health Retailers
  • eCommerce
  • Big Box / Food and Drug Mass
  • Doctor Practitioner
  • Convenience

HempFusion’s Line of Products

HempFusion’s branded line of products is based on the company’s proprietary Whole Food Panoramic Full-Spectrum Hemp Complex. Each product is condition-specific, targeting needs such as sleep, energy and stress.

All of HempFusion’s products are made from DNA-verified, European Union registered, non-GMO, organic industrial hemp. The company’s offerings span multiple product categories, including:

  • Tinctures and capsules – These offerings make up the most popular product category in the $4 billion U.S. CBD market.
  • OTC topicals – HempFusion is one of the few CBD companies marketing FDA Drug Listed Topicals. The FDA compliance standards ensure that these products meet the standards set by larger national retailers.
  • Condition-specific OTC products – HempFusion has OTC products that are condition-specifically targeted, including:
    • OTC Pain Products – The global pain relief market for topicals is projected to reach $13.3 billion by 2025, with a CAGR from 2018 to 2025 of 7.4%.
    • OTC Eczema Products – The global dermatitis market is projected to reach $13.6 billion by 2026.
    • OTC Acne and Aging/Beauty Products – The global market for beauty and anti-aging products is currently estimated at $1.08 trillion.
    • OTC First Aid and Wound Healing Products – In 2019, the 10 top-selling first aid ointments in the United States generated over $650 million in sales.

Probulin Probiotics and Digestive Enzymes

Probulin Probiotics is a 100% wholly owned subsidiary of HempFusion Wellness Inc. and is currently one of the fastest growing probiotics brands in the United States, according to Spins syndicated data.

The Probulin product line addresses a wide range of consumer needs, including daily care, total care, women’s health and children’s products. The probiotics market represents a growing opportunity, as it is estimated to reach $7 billion globally by 2022.

Because of the diverse offerings of the Probulin line, it serves as HempFusion’s gateway to retailers who may not currently carry CBD products.

This ‘Trojan Horse Strategy’ is intended to allow the company to establish, develop and build relationships among these retailers. By achieving approved vendor status, the company may be able to facilitate faster onboarding times, enabling accelerated access to its CBD products in the future.

HF Labs and Biome Research – Doctor and Practitioner Product Lines

The HF Labs and Biome Research product lines are directed toward doctors and practitioners and cater to hospitals, compounding pharmacies and free-standing dispensaries. With an estimated target market of 28,000+ integrative medical doctors and 70,000+ licensed chiropractors in the United States, these offerings create a unique market opportunity as HempFusion continues to broaden its footprint in the CBD industry.

Research on CBD and Human Safety

HempFusion is one of 12 CBD companies selected to participate in ValidCare’s groundbreaking study regarding CBD and human safety, which is expected to be complete by the end of October 2020. The study is designed to address previous questions from the FDA regarding CBD products.

As part of this study, HempFusion and the other selected companies will be conducting human trials to determine if the daily use of full-spectrum hemp-derived CBD or CBD isolate impacts the human liver.

Management Team

Jason Mitchell, N.D., is the co-founder, Director and CEO of HempFusion. He has over 20 years of experience in the natural products industry and is a naturopathic doctor certified by the ANMCB. Mitchell received his doctorate from the Trinity College of Natural Health and is a member of the American Naturopathic Medical Association and the CNHP. He is an expert in supplemental formations and was responsible for successfully creating and launching over 300 industry-leading products during his 15-year tenure at Country Life Vitamins.

Ian DeQueiroz is the Chief of Brand Strategy & Partnerships and a Director for HempFusion. He is a serial entrepreneur with experience in early-stage cannabis and hemp companies. In 2010, he acquired his first cannabis CO2 extraction company in the United States. DeQueiroz has facilitated the licensing process for many companies in the United States, as well as one of Jamaica’s premier cannabis companies, Epican Medicinals Ltd.

Jon Visser is HempFusion’s Chief Revenue Officer. He has over 25 years of experience in all areas of sales and marketing, with a proven track record of consistently driving growth across all major channels. Visser was previously the Senior Vice President of Sales at Navajo Inc., a multi-national manufacturer/distributor of brands like Pennzoil Automotive Supplies, Piranha Eyewear and Navajo Inc., the largest distributor of trial- and travel-sized health and beauty products in the United States. Visser grew annual sales from $60 million to $128 million in less than three years while at Navajo Inc.

Bruce Valentine Jr. is the Chief Financial Officer of HempFusion. He has a proven track record working with high-growth companies and was named CFO of the Year in 2013 by the Northern Colorado Business Report. Valentine is the former CFO of Otter Products and has over 15 years of financial management experience.

Ola Lessard is the Chief Marketing Officer of HempFusion and is also the President of the U.S. Hemp Roundtable. She has experience in marketing creative and effective brand strategies. She is a former Vice President of Marketing at Barlean’s, an award-winning supplements provider based in Washington.

Nancy Angelini is the Director of the Doctor/Practitioner Channel. She has over 25 years as an active, licensed practitioner. Angelini travels the country as a lecturer and product manager. She is responsible for opening doors to some of the largest doctor/practitioner networks in the United States.

Daniel Brody is the Chief Corporate Officer of HempFusion. He is the co-founder and former Vice President of The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF). Brody has been instrumental in listing multiple world-class cannabis companies, including TGOD, Emblem Corp. and Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF). Before joining the cannabis industry, he spent seven years working at two leading Canadian brokerage firms.

HempFusion Wellness Inc. (CBDHF), closed Wednesday's trading session at $2.70, up 1.1236%, on 183,305 volume with 500 trades. The average volume for the last 3 months is 175,110 and the stock's 52-week low/high is $1.65999996/$3.00.

Recent News

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

The QualityStocks Daily Newsletter would like to spotlight XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT).

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) was featured today in a publication from PsychedelicNewsWire, examining how, according to recent research conducted in America that involved 952 individuals, psychedelic researchers who admitted to using psychedelic substances are often viewed by their abstinent counterparts as having less integrity. The study, which was reported in the “Public Understanding of Science” journal, proposes that stereotypes about both psychedelics and the individuals who use them may affect an individual’s view of researchers.

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. This includes products that are being readied for commercialization within the coming weeks, such as a rapid COVID-19 PCR test kit that reduces turnaround times to less than 30 minutes.

The company has research and development operations in North America and Europe and an operational focus in Germany. Its regulatory approval and commercialization focus is currently on products for the European market.

XPhyto was founded in 2017 and is headquartered in Vancouver, British Columbia.

Business Strategy & Milestones for 2021

On January 18, 2021, XPhyto issued a news release detailing its business strategy for the coming year. The company noted that it is “on the cusp of transformational change as product development programs advance from the laboratory to the clinic.” In addition to continuing to leverage its scientific expertise and operations in North America and Europe for product development and optimization, XPhyto intends to pursue growth through the commercialization of existing products and adherence to a focused investment strategy targeting impact-driven innovation with “the potential for extreme value creation.”

In particular, XPhyto is well positioned to execute on opportunities across its current business divisions, including:

  • Commercialization of infectious disease diagnostics
  • Clinical validation of transdermal and sublingual drug formulations
  • Continued investment and development in psychedelic medicine

“2020 was a very productive year for XPhyto. We made significant progress in all areas of our business,” Hugh Rogers, CEO & Director of XPhyto, stated in the update. “We have ambitious milestones for 2021 with multiple product launches on the horizon, multiple clinical drug programs underway, and an aggressive commitment to psychedelic medicine. I am extremely confident that our team can execute on the company’s business plan for 2021.”

Infectious Disease Diagnostics

XPhyto’s lead diagnostic product, secured through an exclusive global commercialization agreement with 3a-diagnostics GmbH (“3a”), is a rapid and highly portable PCR diagnostic test. Notably, PCR testing “has emerged as the only internationally recognized standard for COVID-19 testing” and is expected to play a key role in facilitating the recovery of the domestic and international travel industries, among others.

Successful validation of the PCR system was achieved in Q4 2020, and XPhyto has expressed confidence that it will achieve European commercial (CE-IVD) approval in Q1 2021. In preparation for this milestone and an anticipated Q1 product launch, the company is currently in discussion with manufacturing and distribution partners in Europe and the Middle East.

In addition to COVID-19 products, XPhyto and partner 3a are developing and commercializing a portfolio of low-cost oral biosensors. The company’s lead biosensor product is an oral health screening test for the detection of peri-implantitis for which XPhyto is targeting a late 2021 European commercial approval.

XPhyto does not make any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 pandemic.

Drug Formulation & Delivery

In 2020, XPhyto’s German subsidiary, Vektor Pharma TF GmbH (“Vektor”), reported significant advancement in four therapeutic programs targeting neurological indications with significant market demand. Vektor also successfully developed a sublingual drug formulation on contract for a major generic drug manufacturer and distributor.

XPhyto will look to build on this progress in 2021, with plans to complete human pilot studies evaluating its four lead therapeutic products:

  • Rotigotine transdermal patch for Parkinson’s disease
  • CBD oral/sublingual strip for treatment resistant epilepsy
  • THC oral/sublingual strip for anorexia/nausea
  • CBD:THC (1:1) oral/sublingual strip for multiple sclerosis associated spasticity

Per its 2021 business update, the company is currently in “ongoing discussions with multiple potential commercial partners, licensors and distributors and will be reviewing monetization opportunities on a continued basis.”

Psychedelic Medicine

Psychedelic compounds are a highly promising new class of active pharmaceutical ingredient (“API”) demonstrating strong potential for a variety of mental health conditions. XPhyto is positioned to capitalize on this promise through two strategic initiatives:

  • An agreement for the development of industrial scale biotechnology processes for the production of psilocybin
  • An agreement for R&D related to multiple psychedelic compounds, including psilocybin, mescaline, LSD, MDMA and DMT, among others

XPhyto intends to advance and expand its programs focused on the industrial scale production of psychedelic API in 2021. The company also plans to launch new programs for the development of psychedelic drug formulations, with a focus on sublingual and transdermal therapeutics and the integration of these products into established clinical programs relating to mental health indications.

Management Team

Hugh Rogers is the CEO and Director of XPhyto Therapeutics Corp. He is an entrepreneur and lawyer with private and public start-up company experience in various industries and operational roles. His recent advisory work has focused on public listings and corporate restructuring. This restructuring has occurred in the life science (cell therapy and medical device) and natural resources (natural gas co-gen and conventional oil) industries. Mr. Rogers holds a bachelor’s degree in Cellular Biology and Genetics and a law degree. He is a member in good standing of the Law Society of British Colombia.

Christopher Ross is the CFO of XPhyto. He is a professional accountant with broad financial experience across numerous industries, including forestry, distribution, construction, mining and multi-family real estate. He has provided advisory services to private and public companies in the areas of financial accounting, strategic analysis, audit and taxation. Mr. Ross holds a bachelor’s degree in commerce. He is a member in good standing with the Chartered Professional Accountants Association of British Columbia.

Wolfgang Probst serves as Director of XPhyto and Managing Director of BUNKER Pflanzenextrakte GmbH. He is a seasoned management and financial consultant based in Bavaria, Germany. He has consulting experience as branch head working with private clients and corporations of high net worth. In 2017, Mr. Probst assumed the CFO role of BUNKER and continues to play a key role in its operational and financial development.

Professor Dr. Raimar Löbenberg serves as Director of XPhyto. He holds a Bachelor of Science in pharmacy from Johannes Gutenberg-University and a Ph.D. in pharmaceutics from the Johann Wolfgang Goethe-University. He is the co-founder of RS Therapeutics Inc., which concentrates on foam-based topical drug delivery systems.

Professor Dr. Thomas Beckert is the Founder and Managing Director of Vektor Pharma TF GmbH. His expertise includes the formulation and machine development of transdermal therapeutic systems and ODFs. Professor Beckert holds a Bachelor of Science in pharmacy from the University of Freiburg and a Ph.D. in pharmacy and economics from the University of Tubingen.

XPhyto Therapeutics Corp. (OTCQB: XPHYF), closed Wednesday's trading session at $2.53, up 1.6064%, on 264,464 volume with 953 trades. The average volume for the last 3 months is 43,910 and the stock's 52-week low/high is $1.3125/$3.0999999.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it had closed on its previously announced registered direct offering. The offering, comprised of 4,222,288 shares of POAI common stock sold at $1.75 per share, totaled $7.4 million in gross proceeds for the company, before expenses were deducted. The shares were priced at-the-market under Nasdaq rules. To view the full press releases, visit https://ibn.fm/Tjdjf and https://ibn.fm/VyyW1

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Wednesday's trading session at $2.20, up 34.1463%, on 20,168,401 volume with 37,580 trades. The average volume for the last 3 months is 3,206,273 and the stock's 52-week low/high is $0.629999995/$4.42000007.

Recent News

Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF)

The QualityStocks Daily Newsletter would like to spotlight Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF).

Josemaria Resources Inc. (TSX: JOSE) (OTCQB: JOSMF) was featured today in a publication from MiningNewsWire, examining how the coronavirus pandemic has brought some of the biggest economies in the world to their knees, while affecting many other industries across the globe. However, it has also brought forth a few positive effects, such as the advancement of the fourth industrial revolution, by adopting technology, especially in the natural resource industry.

Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF) is a Canadian natural resources company based in Vancouver, British Columbia. The company’s current focus is on advancing the development of its wholly owned Josemaria copper-gold mining project.

Josemaria Resources is part of The Lundin Group of companies, a conglomerate of 13 business entities operating in the mining, oil and gas and renewables sectors all around the world.

The Josemaria Copper-Gold Project

The company’s flagship Josemaria Copper-Gold Project is located in the San Juan Province of Argentina – a well-known mining hub supporting a wide variety of mining service companies. The Lundin Group has been active in Argentina for approximately 30 years. Committed to advancing the project, Josemaria Resources has already begun the bridging phase, with basic and detailed engineering planning expected to commence in early 2021.

The company recently announced the results of a feasibility study at the Josemaria Project. The study, prepared by a team of engineering and consulting providers including Fluor Canada Ltd., SRK Consulting (Canada) Inc. and Knight Piésold Ltd., highlights a robust, low-risk project with rapid payback expected via an open pit operation with forecast capacity to feed a conventional process plant at a rate of 152,000 tonnes a day over a 19-year mine life.

According to the feasibility study, the project is expected to yield an average annual production of 136,000 tonnes of copper, 231,000 ounces of gold and 1,164,000 ounces of silver. Other highlights of the study include:

  • The optimized mining production plan provides average grades in the first three years of production that are notably better than the life-of-mine average. This supports a forecast 3.8-year payback period from the start of production.
  • The project’s total initial cost, including engineering, procurement, construction, management, on- and off-site infrastructure, contingency and pre-construction engineering work, amounts to roughly $3.09 billion.
  • The location provides readily available access to essential resources, including water, grid power, transportation and logistics infrastructure within San Juan Province.
  • An Environmental and Social Impact Assessment (ESIA) of the project is already underway and is expected to be submitted to relevant authority agencies for review during Q1 2021.

The Josemaria Copper-Gold Project has been designed to incorporate the latest technology. Per the feasibility study, the project will include the use of autonomous trucks and production drill fleets, with the option of incorporating green energy, indicating the company’s commitment to minimizing and mitigating the adverse effects of mining on the environment.

To this end, the company intends to leverage suitable planning, impact assessment and monitoring tools while also incorporating water and energy efficiency systems and ecosystem conservation services in the design and implementation of its operations.

Josemaria Resources President and CEO Adam Lundin welcomed the results of the study as confirming that this is one of the very few readily developable copper-gold projects in the world and forecasting an attractive economic outcome for the asset, comparable with other copper-gold projects in development.

“We believe that Josemaria is perfectly positioned to commence production by mid-decade, meeting rising copper demand from a rapidly electrifying global economy. I believe the study results will allow us to unlock various financing opportunities as we move toward construction,” Lundin said in a news release.

Market Outlook

The global smart mining market was estimated at $6.8 billion in 2019. It is forecast to reach $20.31 billion by 2025. The significant increase is expected to be driven by technological advancements within the sector.

Global demand for copper is also growing steadily, due to the metal’s versatility and multiple uses for industrial, domestic and high-technology indications. The global copper market is expected to reach $222.1 billion by the end of 2026.

Management Team

Adam Lundin is the President, CEO and Director of Josemaria Resources. He has several years of experience in managing capital markets and public companies across the natural resources sector. His background includes oil, gas, mining technology, investment advising, international finances and executive management. Lundin began his career working for several of the Lundin Group mining companies. He is currently engaged in multiple roles, as he is also the Chairman for Filo Mining Corp. and Africa Energy Corp. and a Director of NGEx Minerals Ltd. and the Lundin Foundation.

Ian Gibbs serves as CFO of Josemaria Resources. He is a Canadian Chartered Accountant and a graduate of the University of Calgary, holding a Bachelor of Commerce degree. Gibbs has held many prominent positions within the Lundin Group of companies over the last 15 years, most recently as the CFO of Africa Oil Corp.

Arndt Brettschneider is the company’s Vice President of Projects. He has over 23 years of international mining, consulting and project development experience. Before joining Josemaria Resources, he was Vice President of the mining consulting businesses of two globally recognized engineering companies. Brettschneider obtained a Bachelor of Science with Honors from the University of Queensland in Brisbane, Australia. He received his MBA from Queen’s University in Ontario, Canada.

Bob Carmichael is the company’s Vice President of Exploration. He joined Josemaria Resources from Lundin Mining Corporation’s UK office. In his UK role, he was the General Manager of Resource Exploration. Carmichael is a registered Professional Engineer in the Canadian province of British Columbia. He obtained a Bachelor of Applied Science from the University of British Columbia. His dual role includes serving as Vice President of Exploration for Filo Mining Corp. and NGEx Minerals Ltd.

Alfredo Vitaller is Josemaria Resources’ General Manager in Argentina. He has been involved in the mining industry since 1993. He graduated as a Licentiate in Geological Sciences from Buenos Aires University and has an M.Sc. from Mackay School of Mines at the University of Reno. Vitaller has worked with the Lundin Group since 1993 and was a part of the exploration teams for Filo, Helados and Josemaria.

Notable Directors

Ashley Heppenstall, chairman of the Josemaria Resources board of directors, has over 30 years of experience in the oil and gas and resources sectors. From 2002 to 2015, Heppenstall served as the President, CEO and Finance Director of Lundin Petroleum AB, an oil and gas exploration and production company with core assets in Norway and Southeast Asia. He is credited with building Lundin Petroleum into the largest independent oil firm in the world today, leveraging a single equity raise of $50 million to guide Lundin in the design and implementation of a strategy that’s led it to a current market cap of roughly $6 billion.

Ron Hochstein has worked for the Lundin family directly as a consultant for over 20 years and is currently the President and CEO of Lundin Gold, a gold-producing business whose key asset is the Fruta del Norte gold deposit in Ecuador. Hochstein led construction efforts on the first mine in Ecuador, which went into production in 2019 and was completed on time and on budget.

Paul Conibear has been with The Lundin Group for over two decades, including serving as the CEO and Director of Lundin Mining from 2011 through 2018. Lundin Mining’s current market cap is estimated at $3.5 billion. In total, Conibear has more than 35 years of experience in progressively more responsible positions in the resource sector ranging through management of all phases of mine investment, including exploration, economic assessments, construction, operations and closure.

Josemaria Resources Inc. (TSX: JOSE) (OTC: JOSMF), closed Wednesday's trading session at $0.55565, up 0.624774%, on 42,331 volume with 19 trades. The average volume for the last 3 months is 15,337 and the stock's 52-week low/high is $0.465299993/$0.685000002.

Recent News

Friendable Inc. (FDBL)

The QualityStocks Daily Newsletter would like to spotlight Friendable Inc. (FDBL).

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, is uniquely positioned to capitalize on live streaming growth opportunities in the entertainment space, especially in the music sector, through its Fan Pass platform.

Friendable Inc. (FDBL) is a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications. Launched July 24, 2020, the company’s flagship offering is designed to help artists engage with their fans around the world and earn revenue while doing so. The livestreaming platform supports artists at all levels, providing exclusive artist content ‘Channels’, LIVE event streaming, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist.

With Fan Pass, artists can offer exclusive content channels to their fans, who can use their smartphones to gain access to their favorite artists, as well as an all-access pass to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists – all available to fan subscribers on a free trial basis. Subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, and VIP experiences are available at a fraction of the cost of traditional face-to-face meetups.

Friendable Inc. was founded by Robert A. Rositano Jr. and Dean Rositano, two brothers with over 27 years of experience working together on technology-related ventures.

The Fan Pass Mobile & Desktop App

Friendable Inc. launched its Fan Pass platform as a solution for artists and their fans as the COVID-19 pandemic and the associated shutdown have continued to severely hamstring the entertainment industry as a whole. Through Fan Pass, the company aims to reach artists at all levels looking to alter their touring schedules to include ‘Virtual Touring’, new revenue sources and innovative fan engagement opportunities that are expected to become permanent fixtures of artists’ touring routines moving forward.

Fan Pass creates an ecosystem that embraces fans of all kinds, feeding diehard followers and developing lasting connections with more casual supporters. Through the app, qualified artists are provided with a custom designed, exclusive ’Fan Pass Channel’ where they can invite fans and social followers from anywhere around the world to join in chats and live events – allowing fans to experience all there is to see of an artist in one place. Artists earn revenue from monthly fan subscribers, merchandise sales, tickets sold for virtual streaming events and generally from all content views or impressions on their channels. All content views and sales of every kind are reported to each artist through their dashboards, including real-time payout and earnings information.

Fan Pass’ exclusive ‘All Access VIP’ option provides fans with access to content, such as:

  • Live performances or online concerts
  • Backstage meetups before, during or after events
  • Livestreams of studio sessions
  • Behind-the-scenes footage of music video and photo shoots
  • Special interviews and one-on-one videos
  • Streams highlighting the artists’ daily lives

The Fan Pass platform is extremely intuitive, bringing each artist through a streamlined onboarding process, including building out artist ‘Channels’, scheduling LIVE events and designing special edition merchandise to be offered solely through exclusive Fan Pass merchandise stores.

“With the global pandemic disrupting the entertainment industry in such a profound way, artists have had to look to digital distribution and live virtual performances in order to maintain any earning opportunities. Fan Pass and our team are determined to provide solutions and support to all artists, their fans and the industry in general. We are excited about the opportunity we have to shape the future of virtual entertainment, revenue generation and artist/fan engagement,” Robert A. Rositano Jr., CEO of Friendable Inc., stated in a news release.

Market Opportunity

Artists rely heavily on revenue streams that are not often seen by those without intimate industry knowledge. When it comes to traditional performances, the sale of VIP/backstage or meet & greet passes to boost revenue can often become the majority of the artist’s annual tour revenue. Data provided by one of the company’s original entertainment partners, The Kluger Agency (TKA), suggests that as much as 18-23% of artists’ annual tour revenue has historically been derived from these VIP experiences.

The World Economic Forum reports that, in 2020, the six-month-plus disappearance of live music concerts is estimated to have cost “the industry more than $10 billion in sponsorships,” and individual artists are feeling the loss the most. Fan Pass is helping to bridge this gap, providing more affordable virtual VIP experiences that can be offered simultaneously to fans around the world.

While it’s free for artists to join, Fan Pass leverages a monthly subscription model paid by fans to generate revenues. These revenues are shared with all channel artists. In exchange for its platform features, live streaming tools, bandwidth, processing and handling, Fan Pass earns platform fees on each separately ticketed event, as well as splits with each artist on subscriber fees and merchandise designed and sold on the platform.

The U.S. video streaming industry is expected to hit $7.08 billion in value in 2021, with an estimated 100 million internet users watching online video content every day, according to data from Livestream.com. The same report suggests that 45% of live video audiences would pay for exclusive, on-demand video from a favorite team, speaker or performer. Through Fan Pass, Friendable Inc. is uniquely positioned to capitalize on this opportunity.

Friendable App

The company’s second application, Friendable, is an all-inclusive platform where users can meet, chat and date. The app has exceeded 1.5 million total downloads, with over 900,000 historical registered users and more than 580,000 historical user profiles.

Friendable Inc.’s Next Phase of Growth

To facilitate its next phase of growth, Friendable Inc. is seeking an additional $1 million in equity investment, with a follow-on funding that meets or exceeds $5 million. The company intends to utilize its relationships to secure the lowest cost of capital available, as these funds will drive technology advancements, increase head count, fund marketing initiatives and secure additional celebrity talent aimed at bringing larger fan audiences to each released event. These initiatives will assist in building recurring monthly (fan) subscribers, effectively generating recurring monthly revenue for each artist, as well. The next phase of growth is expected to play a key role in accelerating the company’s download and conversion of data for subscription revenue and merchandise sales.

The company’s primary goal is to establish Fan Pass as a premier brand and mobile platform dedicated to connecting and engaging users around the world. In support of this goal, it has entered into a partnership with Brightcove targeting OTT platform expansion, including leaders such as iOS, Android, Apple TV, Android TV, Roku and WWW.

In the highly competitive video streaming market, Friendable Inc. has tapped into an unmet demand from today’s ever-present ‘omni-users’ for constant contact with celebrities and influencers. Via Fan Pass, the company offers investors an opportunity to gain a stake in an organization catering to this new breed of omni-users and their influencers.

The application’s potential is clearly illustrated by the interest it has generated in recent weeks. From September 4 to October 12, the Fan Pass platform added 246 new artists, accounting for a 410 percent increase in just six weeks.

“We are extremely encouraged by the ongoing swell of interest as the value of our Fan Pass platform continues to resonate in the artist community,” Friendable CEO Robert A. Rositano Jr. stated in a news release. “We believe the live streaming functionality, our full-circle offering and diverse revenue opportunities the platform offers will continue to drive exponential growth as management remains focused on building long-term shareholder value.”

Management Team

Robert A. Rositano Jr. is the co-founder and CEO of Friendable Inc. He oversees the daily management and operational duties of all areas of the business. He has over 20 years of experience as a serial entrepreneur, bringing in over $60 million in liquidity events for the companies he has created or managed. Before starting Friendable Inc. with his brother, Rositano was a founding member of the internet’s first IPO, Netcom Online Communications Inc. It was sold to ICG, then to EarthLink in 1995. He has been a co-founder of several successful ventures, including Simply Internet Inc., Nettaxi.com and America’s Biggest Inc., among others. He also authored one of the first web directories for MacMillan Publishers.

Dean Rositano is the co-founder and Chief Technology Officer of Friendable Inc. He handles the day-to-day operations and guides the technical direction of the company. He has over 15 years of executive management, financial management, high technology operations and internet architecture experience. Before co-founding Friendable Inc., Rositano co-founded several other companies, including Checkmate Mobile Inc. and Latitude Venture Partners LLC, among others.

Friendable Inc. (FDBL), closed Wednesday's trading session at $0.0473, up 2.8261%, on 8,683,161 volume with 473 trades. The average volume for the last 3 months is 4,192,343 and the stock's 52-week low/high is $0.007799999/$0.289999991.

Recent News

Brain Scientific Inc. (OTCQB: BRSF)

The QualityStocks Daily Newsletter would like to spotlight Brain Scientific Inc. (OTCQB: BRSF).

Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company with two FDA-cleared products, has entered into a memorandum of understanding (“MoU”) with Ehave, Inc. (OTC: EHVVF), a provider of digital therapeutics for the psychedelic and mental health sectors. The agreement calls for the two companies to work together to map brain response to psychedelics being administered as a treatment for chronic pain, depressions (both major and persistent), post-traumatic stress disorder, bipolar disorder, general anxiety, ADHD and schizophrenia. To view the full press release, visit: https://ibn.fm/jwPjg

Brain Scientific Inc. (OTCQB: BRSF) is a commercial-stage health care company focused on developing innovative and proprietary medical devices and software. With a mission of modernizing brain diagnostics by employing cutting edge technologies to bridge the widening gap in access to quality care, the company offers two FDA-cleared products that provide next-generation solutions to the neurology market.

The company’s proprietary, clinical-grade neurological devices are supported by its intellectual property portfolio featuring patents in the United States, China and Europe.

Brain Scientific’s first commercialized devices, NeuroCap(TM) and NeuroEEG(TM), are designed to disrupt the current electroencephalogram (EEG) market by offering cost-effective and disposable substitutes to existing solutions, allowing medical professionals to collect diagnostic information quickly.

The company’s goal is to improve diagnostics by leveraging artificial intelligence and machine learning processes to analyze a database of brain readings as a method of detecting seizures and dementia. The company is also working to improve patients’ access to neurological care.

Headquartered in New York, Brain Scientific and its predecessor (and now wholly owned subsidiary, MemoryMD Inc.) was founded in 2015 and went public in 2018.

Brain Scientific’s first phase of development, from 2018 to 2019, saw the inception of portable, clinical-grade, easy-to-use neurological devices. The second phase, currently ongoing, aims to create cloud-based, secure infrastructure to transmit patient data between patients and their neurologists. The company’s third phase of development is scheduled for 2021-2022 and is expected to focus on the use of AI-assisted diagnostic analysis to increase the efficiency, consistency and accuracy of neurology specialists.

NeuroCap(TM) – Disposable EEG Headset

The NeuroCap is a disposable pre-gelled EEG headset featuring 22 electrodes and 19 active EEG channels, all adhering to the international 10-20 system. The NeuroCap was FDA-cleared in 2018. The headset can be used for recording EEGs in virtually any setting, including urban and rural emergency departments, neurology clinics, urgent care clinics, ICUs, nursing homes, assisted living facilities and remote clinical research labs.

Through a universal cable adapter, the NeuroCap is compatible with other EEG amplifiers. The cap also works in parallel with Brain Scientific’s NeuroEEG amplifier, initiating EEG studies in less than five minutes.

The company is currently seeking FDA approval for additional features for the NeuroCap, as the device has the potential to fill a gap in EEG testing availabilities during the current coronavirus pandemic: in October 2020, Brain Scientific filed an Emergency Use Authorization (EUA) application. The EUA is required for the rapid distribution of the NeuroCap device to emergency departments, intensive care units and other treatment centers to administer prescriptive EEGs safely on critically ill patients or those suspected of being diagnosed with COVID-19.

With more than 80 percent of hospitalized patients infected with COVID-19 displaying neurological symptoms, the NeuroCap could prove to be a valuable device by offering fast testing with limited contact between technicians and patients.

NeuroEEG(TM) – Miniature and Portable Wireless EEG Amplifier

The NeuroEEG is a compact, portable and affordable wireless EEG amplifier intended for prescription use. The 16-channel, FDA-cleared, clinical-grade device acquires, records, transmits and displays electrical brain activity for patients of all ages.

Both the NeuroCap and NeuroEEG are delivered by MemoryMD Inc., a wholly owned subsidiary of Brain Scientific.

Products in Active Development

Currently, Brain Scientific and MemoryMD are working on leveraging their existing products and drawing from ongoing research to develop and commercialize the next generation of solutions for the brain diagnostics market. The devices under development are being designed to address the following issues:

Routine EEG

  • NeuroCap-8 is an 8-channel EEG cap. The reduced number of electrodes is vital in emergency room situations, where the time it takes to set up the EEG is critical.

Pediatric EEG

  • NeuroCap Pediatric is positioned to become the first disposable and pre-gelled headset available for the pediatric market.

Long-Term Monitoring

  • NeuroCap LTM for adult and pediatric patients is a disposable cap designed to monitor rhythmic and periodic patterns for up to 72 hours, providing essential diagnostic capabilities.
  • NeuroEEG 24 Channel Amplifier is a portable and wireless amplifier with over 24 hours of battery life.

Artificial Intelligence

  • Brain E-Tattoo is a minimally invasive four-channel EEG electrode designed for long-term monitoring.
  • An AI database of brain biomarkers collects data on both normal and abnormal brain data to detect neurological diseases. The goal is for machine learning algorithms to enhance understanding of brain-behavior related to epilepsy, memory dementia and pre-Alzheimer’s diagnostics.

Telemedicine

Brain Scientific is expanding the vision for telemedicine in neurology. The company aims to address the current acute neurologist shortfall (20 states have less than 10 neurologists per 10,000 patients) through the use of teleneurology.

 

Partnership with Marketing Brainology

Brain Scientific has a longstanding partnership with Marketing Brainology, a neuromarketing firm using neuroscience approaches to understand consumer behavior. In 2019, Marketing Brainology conducted a study using NeuroCap and NeuroEEG to determine the most effective Super Bowl commercials.

“Thanks to Brain Scientific’s NeuroCap and NeuroEEG, we are able to better understand the art and science of the human decision-making process,” Michelle Adams, Ph.D, Founder of Marketing Brainology, stated in a news release.

In April 2020, Marketing Brainology again conducted a study leveraging Brain Scientific’s disposable EEG cap to determine how brains were reacting to COVID-19 messaging. Subjects were presented with multiple media impressions, and Marketing Brainology analyzed their responsive biomarkers. The results identified the most effective messaging for engaging with an audience during a crisis.

Market Outlook

The current global market for EEG devices is estimated at $956.1 million. It is expected to rise with a CAGR of 8.7% from 2019 to 2026, reaching $1.6 billion in value by 2026, according to Grandview Research.

In total, there are approximately 6,150 hospitals in the U.S., according to the American Hospital Association. Critically, though, just 254 of those hospitals are certified Level 4 Epilepsy centers with 24/7 EEG coverage. Since very few non-Level 4 centers have extensive EEG tech coverage, this creates a significant opportunity for Brain Scientific to bridge the gap by providing over 5,900 hospitals with lower cost amplifiers and disposable EEG caps.

The company also see opportunities to work with other businesses, such as EEG manufacturers hoping to package Brain Scientific’s solutions with their products, which could greatly expand Brain Scientific’s addressable target market.

Management Team

Dr. Baruch “Boris” Goldstein, Ph.D., is co-founder and Chairman of Brain Scientific. He is a seasoned executive with a proven talent for aligning global business strategies with established and emerging management teams. Goldstein’s growth-focused leadership style has helped him raise over $750 million in venture capital for the development of innovative companies and startups in diverse industries, including financial services, biomedicine, alternate energy and new materials, as well as groundbreaking work in artificial intelligence. His recent achievements include important advancements in neurology and unlocking the potential of AI correlations and machine learning applied to life sciences and medical research. He built a suite of first-to-market companies as a technology-oriented leader, including Ryah Medtech, Brain Scientific, GrapheneCA, E-Forex and Intelligent Video Systems. He also co-founded BrainRX, a company specializing in pre-Alzheimer’s diagnostics.

Dr. Nikolay Kukekov, Ph.D., is a Director of Brain Scientific and a partner at HRA Capital. Before joining HRA Capital, Kukekov was Managing Director of Healthcare Investment Banking at Summer Street Research. His scientific background includes a bachelor’s degree in Molecular, Cellular and Developmental Biology from the University of Colorado at Boulder. He earned his Ph.D. in neuroscience from Columbia University – College of Physicians and Surgeons in New York.

Stuart Bernstein is the company’s Vice President of Marketing. He was recently named to the role after spending the first part of his professional career in senior technical management roles with Fortune 500 companies such as NCR (NYSE: NCR), IBM (NYSE: IBM) and Control Data Corp. He was the CEO of BioSignal, an EEG medical device company. He is also a co-founder of several software engineering and telemedicine firms. One of them, Brain Saving Technology, is now Specialist on Call (SOC Telemed) – a leading telemedicine company that powers over 850 facilities for teleneurology, telepsychiatry and critical care telemedicine with over 200 physicians.

Brain Scientific Inc. (OTCQB: BRSF), closed Wednesday's trading session at $1.50, even for the day, on 4,998 volume with 18 trades. The average volume for the last 3 months is 11,126 and the stock's 52-week low/high is $0.100000001/$3.00999999.

Recent News

CannAssist International Corp. (OTCQB: CNSC)

The QualityStocks Daily Newsletter would like to spotlight CannAssist International Corp. (OTCQB: CNSC).

Carefully developing and executing a strategic go-to-market plan has never been more important for companies operating in the cannabis industry, according to a recent “Rolling Stone” article (https://cnw.fm/uMoi5). The article urges cannabis companies to consider the industry from both a competitive perspective as well as an opportunity angle, which is exactly what CannAssist International (OTCQB: CNSC) has done as it looks toward 2021 and a projected $5.8 million share of the market. Also today, CannabisNewsWire released a report on the company as CNSC was featured in an episode of The Bell2Bell Podcast, produced by InvestorBrandNetwork (“IBN”) as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Bell2Bell’s latest podcast features Mark Palumbo, founder and CEO of CannAssist, as he discusses the company’s CiBiDinol technology. To view the full press release, visit: https://cnw.fm/lyBZk

CannAssist International Corp. (OTCQB: CNSC), owner of Xceptor Labs, is a biotechnological pharmaceutical and wellness company marketing the Xceptol consumer brand.

CannAssist, a Delaware corporation, was established in May 2017 and is headquartered in San Diego County, California.

2018 Farm Bill and CBD Market Size

Signed into law in December 2018, the Agriculture Improvement Act of 2018 (2018 Farm Bill) removed hemp from its classification as a Schedule I drug under the Controlled Substances Act of 1970.

There are over 100 known cannabinoids within the hemp plant. The two most commonly utilized cannabinoids are THC (tetrahydrocannabinol) and CBD (cannabidiol). Cannabinoids have been shown to affect the endocannabinoid system within the human body, which is why CBD has demonstrated effectiveness as a therapeutic option when delivered through the right absorption avenues.

The 2018 Farm Bill is expected to have a sustained impact on the growth of the cannabidiol market and related sectors. In 2018, the global cannabidiol market was valued at $4.6 billion, and it’s expected to increase almost sixfold by 2025, reaching $23.6 billion (https://ibn.fm/PL6PO).

This growth is expected to provide multiple opportunities to CannAssist and its high-quality, high-performance brands, including products currently under development. Based on current revenue from licensing agreements, retail sales and the Xceptol brand’s international distribution, the company expects to reach first-year sales of $5 million. With additional products in the pipeline and an unwavering commitment to quality and effectiveness, the company expects to see steady sales growth in the years ahead.

Xceptor Labs

Xceptor Labs is an R&D and raw material manufacturing company that partners with TakaUSA, in Coppell, Texas, for contract manufacturing and production services.

CiBiDinol Technology

Xceptor Labs’ technology, CiBiDinol, is formulated using a proprietary process developed by CannAssist Founder Mark Palumbo. It is specifically designed to address many critical issues with oil-soluble CBD molecules, including delivery, bioavailability and short shelf-life. This technology provides the basis for Xceptor Labs and Xceptol consumer products.

CiBiDinol is believed to provide CBD in a format that is more in line with the body’s natural bioactivity. The company’s proprietary processes are used to combine CBD molecules with penetration enhancing cyclodextrin, effectively modifying the CBD molecule’s surface and rendering it water dispersible. This technology enhances absorption through the skin and gut.

The company believes that CBD products created using its CiBiDinol technology offer more predictable potency and enable reduced dosage requirements. This technology clears the way for a wide variety of products, including many oil-soluble active ingredients and highly effective consumer product applications.

Independent Testing

Third-party testing has confirmed that products made with CiBiDinol demonstrate a 400 percent increase in skin penetration as compared to regular CBD in oil carriers alone, as well as a 300 percent higher absorption rate in the gut. The company believes that the results indicate that the amount of CBD needed to achieve targeted endpoints can be significantly lower, resulting in lower costs for manufacturers and consumers with little to no side effects.

“Oversight of manufacturing and third-party testing of this ingredient produced consumer products designed to provide clinicians and consumers safe, effective, and affordable treatment options to address their health and wellness concerns,” Palumbo said in a news release.

CiBiDinol is currently being evaluated for safety by the National Science Foundation for Global Recognition and has been submitted to the FDA’s bulk drug substance program. The company is developing a commerce pathway in each state’s pharmaceutical distribution network through the National Board of Pharmacies. The company aims to capture increasing market share through product extensions and advancements by seeking critical third-party analysis and physician feedback regarding its proprietary technology’s attributes. Xceptor Labs intends to offer licensing arrangements for brand-consumer companies.

Xceptol Products

CiBiDinol technology is the foundation for Xceptor Labs and the Xceptol line of products, including topical creams, capsules, tinctures and pet drops. The Xceptol line began launching its products in September 2020, and it currently has five National Drug Code topical pain creams utilizing ingredients registered with the FDA.

Xceptol products will be sold online, through Range Me, as well as through national and international retail and pharmaceutical distributors. Marketing for Xceptol products is planned through multiple social media campaigns including using celebrities and former athletes associated with Freedman Sports Promotional Relations.

Xceptol is establishing sales channels in North America, Central America, South America, South Africa, the EU, the UK and the Philippines.

Management Team

Mark Palumbo, CEO and Founder, is an entrepreneur, scientist and executive with over 30 years in the health care, laboratory and manufacturing industries. His entrepreneurial endeavors include a successful personal care industry distribution company, a currently owned and operated tissue culture laboratory and Xceptor Labs, now part of CannAssist International.

Marla Palumbo, President, is a health care professional and registered nurse with over 30 years of experience in the industry. She handles sales, patient advocacy, patient care and general management. Marla Palumbo has effectively developed and grown a personal care distribution company with significant year over year increases in sales. Her management and organization skills were instrumental in the early development of Xceptor Labs, leading to its CannAssist International public company status.

Dr. Rahul Dixit, MD, Medical Director, is a doctor of gastroenterology at Providence St. John’s Medical Center in Santa Monica, California. He was part of a double fellowship with the University of Miami in Gastroenterology and Hepatology/Liver Transplant at Johns Hopkins Hospital. He has over 20 years of experience with cannabis and hemp-related products.

Takako McGowan, Managing Director, Founding Member and Owner of TakaUSA, brings 40 years of experience in manufacturing and consumer product research & development to the CannAssist team.

Camron Elizabeth, Managing Director-Sales and Marketing, is an entrepreneur and leader who has brought immense success to the companies with whom she has worked. As Founder and CEO of Platinum Pack, Elizabeth was responsible for all aspects of its success in bringing products from concept to completion and successful sell-through on the retailer’s shelf. She has been in the beauty industry for over 40 years.

Benjamin Perlstein, VP of Operations, has been a part of the health care and business development field for over 25 years. As a surgical technologist, he has experience as a clinical application specialist and materials manager.

Braden Traub, Director of Marketing and Customer Development, is an entrepreneur and business owner with 10 years of experience in the health and fitness industries. Traub also has skills and experience as a tax resolutionist and legal document preparer.

Safe Harbor for Forward-Looking Statements

Forward-looking statements are inherently subject to risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, including, without limitation, the following: the timing and nature of any capital raising transactions; the Company’s ability to offer products and services for use by customers in existing and new markets; the Company’s ability to deliver in a timely fashion and to its customers’ satisfaction the products purchased; the risk of competition; its ability to find, recruit and retain personnel with knowledge and experience in selling products and services in existing and new markets; its ability to manage growth; and general market, economic and business conditions. Additional factors that could cause actual results to differ materially from those anticipated by the Company’s forward-looking statements are under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in its Annual Report on Form 10-K for the fiscal year 2019 and its subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, all filed with the Securities and Exchange Commission. Forward-looking statements are made as of the date hereof, and the Company expressly disclaim any obligation or undertaking to update forward-looking statements.

CannAssist International Corp. (OTCQB: CNSC), closed Wednesday's trading session at $0.06, even for the day, on 230,000 volume. The average volume for the last 3 months is 15,003 and the stock's 52-week low/high is $0.059999998/$0.50.

Recent News

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF)

The QualityStocks Daily Newsletter would like to spotlight TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF).

TAAT(TM) (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) today announced the opening of its online store where consumers in the U.S. can buy the company’s tobacco-free and nicotine-free alternative to traditional cigarettes. The update reads, “Residents of the United States will now be able to purchase TAAT(TM) online!  Cartons of TAAT(TM) Original, Smooth, and Menthol can be ordered to addresses in most U.S. states. It's time for smokers aged 21+ to order TAAT(TM) and make the better choice!” To view the full press release, visit https://ibn.fm/A6lmC

TAAT Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) is a life sciences company dedicated to giving legal-aged smokers the choice to keep the smoking experience that they enjoy with no nicotine and no tobacco.

The key players of TAAT Lifestyle & Wellness are from leading tobacco brands. They are guiding the mission with the company’s proprietary product, TAAT(TM), which uses the company’s proprietary Beyond Tobacco(TM) base material. The base material undergoes a 14-step process to taste and smell just like tobacco and uses a patent-pending refinement technique.

This provides the company with unique opportunities on the global tobacco market, which was estimated at $849 billion in 2019, with approximately 1.3 billion people using tobacco in some form worldwide (https://nnw.fm/bvKFL).

TAAT Lifestyle & Wellness was founded in 2006 and is headquartered in Vancouver, Canada, with operations in Las Vegas, Nevada.

TAAT(TM)

TAAT is a smokable alternative to tobacco cigarettes using the Beyond Tobacco base material, which contains zero tobacco and zero nicotine. The current TAAT offering comes in three varieties: Original, Smooth and Menthol, which were launched during Q4 2020 in Ohio. The company’s Ohio tobacco wholesaler also distributes for major tobacco industry names such as Altria, RJ Reynolds (a subsidiary of British American Tobacco) and ITG.

The TAAT Beyond Tobacco experience was created to replicate the sensory elements of smoking a tobacco cigarette. Market testing in California and Nevada reached a consensus that TAAT products offered no significant differences in experience when compared to tobacco cigarettes, in terms of the following aspects:

  • Visual – the nearly identical product packaging and enhanced smoke volume
  • Auditory – the “crackling” sound of the base material when it is ignited
  • Smell – when burning, TAAT emits a tobacco-like scent
  • Taste – the patent-pending Beyond Tobacco base material undergoes a refinement process that creates a tobacco-like taste
  • Touch – TAAT satisfies the “hand-to-mouth” fixation and motor habits, such as flicking ashes

TAAT Beyond Tobacco Targeting Current Smokers

TAAT Lifestyle & Wellness is currently targeting the market of legal-aged smokers with its proprietary product. The company aims “not to create a new problem, but to solve an existing one.” TAAT Lifestyle & Wellness offers a non-addictive alternative to tobacco, with several competitive advantages making it a promising option on the United States market, such as:

  • Price – TAAT can be offered at a lower price than competing products in the tobacco category, which adds to the propositioned value for current legal-aged smokers.
  • Experience – TAAT appeals to current smokers who wish to give up the tobacco and nicotine but keep the smoking experience they enjoy.
  • Branding/Packaging – TAAT is American-grown and American-made, with its Beyond Tobacco base material serving as a legacy to the combustible tobacco products.

The current alternatives to cigarette smoking do not offer a comparable experience. Previously marketed products, like vaping, proved difficult for some legal-aged smokers to adopt, as the experience was too different from traditional cigarettes.

Market Outlook

In 2016, the United States tobacco market was valued at over $100 billion, a number that’s expected to grow over the next decade (https://nnw.fm/yd8oP). In terms of volume, over 215 billion cigarettes were sold to roughly 34 million adults in the United States in 2018. These numbers represent almost 14% of the adult population. Of those, almost two-thirds smoked more than 15 cigarettes in one day. A standard pack is comprised of 20 cigarettes.

The company’s Beyond Tobacco, as a non-tobacco product, has a price-driven consumer advantage in many states. While state taxes on traditional cigarettes vary, most tend to average around $1.82 per pack. Washington D.C. is on the higher end of the tax spectrum at $4.50 per pack, whereas Missouri is only $0.17 per pack (https://nnw.fm/D3WnT).

TAAT Lifestyle & Wellness estimates that, if one pack of TAAT Beyond Tobacco was sold at 20% of all United States tobacco points of sale, the product would capture 0.25% of the market, the equivalent of approximately 2.7 million cartons of cigarettes per year.

Management Team

Setti Coscarella is the Chief Executive Officer of TAAT Lifestyle & Wellness Ltd. He is experienced in investment banking, private equity and entrepreneurship. In 2017, Mr. Coscarella was the lead strategist for Reduced-Risk Products at Philip Morris International. While there, he worked with thousands of smokers to better understand how to position smoking alternatives, developing programs that could help smokers convert to reduced-risk products. Mr. Coscarella holds an MBA from the Schulich School of Business, specializing in finance, marketing and corporate strategy. He also has a Bachelor of Science in mathematics and physics from the University of Toronto.

Tim Corkum is the company’s Chief Revenue Officer. He has a lengthy history in the tobacco industry, having served 21 years at Philip Morris International. Mr. Corkum has experience leading the international commercialization of combustible cigarettes and working on reduced-risk product offerings. During his 21-year tenure, he held senior positions in business development, sales strategy, key account management and corporate affairs. He holds a BA from Carleton University with a concentration in law.

Joe Deighan is Founder of TAAT Lifestyle & Wellness and oversees research and development. He is the founder of vape liquid ‘JJuice’, created in 2012. JJuice was distributed across all of the United States and in 26 other countries, alongside the private label production that was done for other brands. Mr. Deighan sold JJuice in a cash deal that was valued at over $800,000 in 2017. He currently handles all R&D and production for Beyond Tobacco, knowing the product better than anyone else in the company.

TAAT Lifestyle & Wellness Ltd. (TOBAF), closed Wednesday's trading session at $4.46, off by 5.1064%, on 438,566 volume with 1,039 trades. The average volume for the last 3 months is 247,388 and the stock's 52-week low/high is $0.100000001/$4.73999977.

Recent News

Cybin Inc. (NEO: CYBN) (OTC: CLXPF)

The QualityStocks Daily Newsletter would like to spotlight Cybin Inc. (NEO: CYBN) (OTC: CLXPF).

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) was highlighted in a publication today from FinancialNewsMedia.com, examining how psychedelics are making their way out of the counterculture and back into the mainstream, with research and media interest in the mind-altering substances growing substantially. Some have even called psychedelics “psychiatry’s brave new world.” The revitalization of psychedelics has occurred alongside a shift away from the research and development of traditional psychiatric medications by leading pharmaceutical companies. 

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) is a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products, as well as the functional mushroom market.

The early-stage company boasts an experienced management team featuring industry veterans from pharmaceutical and consumer product backgrounds who have run multiple clinical trials and collectively helped facilitate billions of dollars in product revenues. The team is dedicated to the development of products and protocols within the psychedelic, pharmaceutical and nutraceutical industries.

In particular, Cybin aims to further build upon and expand its intellectual property (IP) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.

Serenity Life Sciences & Natures Journey Inc.

The company’s business model is centered around its two core subsidiaries, Serenity Life Sciences and Natures Journey Inc., which comprise Cybin’s two-pronged approach toward delivering fungi-derived psychedelic and medicinal products.

Serenity Life Sciences is focused on furthering research and development of psilocybin-based medications. Psilocybin is found in certain species of mushrooms and is a non-habit forming, naturally occurring psychedelic compound. Research into psilocybin has shown positive results for the treatment of depression, anxiety, PTSD, addiction, eating disorders, ADHD and other indications.

Natures Journey Inc. operates the Journey brand, which specializes in developing proprietary medicinal mushroom products that target and promote mental wellness, immune boosting detoxification and overall general health and wellbeing.

Partnership with the Toronto Centre for Psychedelic Science (TCPS)

Staying true to its axiom of being a research-first medicinal mushroom life sciences company, Cybin recently announced its entry into a strategic partnership with the Toronto Centre for Psychedelic Science (TCPS), with the goal of furthering its ongoing psilocybin research efforts and expanding Cybin’s psilocybin IP portfolio (http://nnw.fm/9EUkI).

“While there is evidence to support psilocybin as a treatment for certain indications, the Toronto Centre for Psychedelic Science is taking a clinical approach to prove or disprove the safety and efficacy of psilocybin-based microdosing through an open science approach,” Paul Glavine, CEO of Cybin, stated in a news release.

“We are excited to join forces with Cybin and to offer our expertise. A number of firms had approached TCPS, but Cybin demonstrated a superior commitment to high-quality research and integrity in product development. Our high standards for scientific rigor and transparency will find a fitting home within the culture Cybin is cultivating in Canada and abroad,” Thomas Anderson, co-founder of the Toronto Centre for Psychedelic Science, added.

Journey’s Product Monetization & Market Potential for Nutraceutical Supplements

Although Cybin is at the forefront of companies seeking to conduct clinical trials aimed at gaining regulatory approval for psilocybin and other psychedelic products, the company has also placed a great deal of emphasis on generating meaningful revenue from its very outset.

Cybin’s Journey brand has is launching a range of supplements comprised of popular fungi-derived ingredients such as Reishi, Lion’s Mane and Cordyceps. Purported to aid focus and concentration while promoting neurogenesis, Journey’s range of nutraceutical products provides Cybin with a crucial foothold within the non-psychedelic legal supplement market, which is valued at over $25 billion globally and growing at a 9% year-over-year rate.

Pharmaceutical Psychedelics

In addition to the company’s range of non-psychedelic supplements, Cybin has plans to carry out a clinical trial with a new delivery system for its psilocybin-based medications later this year. Ultimately, the company aims to enter into technology transfer agreements with global pharmaceutical companies after phase 1 & phase 2 clinical trials are complete in order to accelerate regulatory approvals in major indications in global markets with entire lifecycle product management.

With products such as psilocybin truffles already legal in nations such as the Netherlands, Jamaica and Bulgaria, Cybin has positioned itself to capitalize on an eventual legalization of psychedelic mushroom-derived products in the future. Working within a regulatory environment with strong similarities to that which dealt with cannabis prior to the industry’s eventual legalization by the Canadian government in 2018, Cybin is laying the groundwork for the moment pharmaceutical psychedelics gain acceptance in North America and abroad.

Amalgamation Agreement and Financing

Cybin recently announced its entry into an amalgamation agreement dated June 26, 2020, with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly owned subsidiary of Clarmin (http://nnw.fm/w04LH). Completion of the transactions contemplated in the amalgamation agreement will result in the reverse takeover of Clarmin by Cybin.

In connection with the proposed transaction, Cybin plans to complete a “best-efforts” brokered private placement of subscription receipts of Cybin, with a syndicate of agents co-led by Stifel Nicolaus Canada Inc. (Stifel GMP) and Eight Capital, to raise a minimum of C$14 million ($10 million) and a maximum of C$21 million ($15 million), with a 15% agents’ option.

To date, Cybin has raised approximately C$10,400,000 through an initial financing round and its series A financing round.

Cybin Inc. (NEO: CYBN) (OTC: CLXPF), closed Wednesday's trading session at $1.60, off by 4.7619%, on 446,410 volume with 685 trades. The average volume for the last 3 months is 509,965 and the stock's 52-week low/high is $0.0284/$2.23499989.

Recent News

Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF)

The QualityStocks Daily Newsletter would like to spotlight Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF).

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has announced additional information regarding PowerTap’s third-generation unit, noting that the unit has increased efficiency and reduced operating costs. The technology and unit are being developed by technology from PowerTap Hydrogen Fueling Corp., an investee company of Clean Power. According to the announcement, the system performance of PowerTap’s third-generation onsite hydrogen production module unit is controlled by advanced operating software with data analytics. To view the full press release, visit https://ibn.fm/3QxsB

Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF) is an investment holding company that focuses on investing in and providing early-stage financing to both public and private businesses. Since its original listing with the Canadian Stock Exchange (“CSE”) on January 23, 2019, the company has made investments in a number of different businesses in a variety of industries, including the energy and cannabis sectors. As per the company’s investment policy, its primary goal is to identify and capitalize on high-return investment opportunities presenting the ability to achieve capital appreciation and liquidity.

Clean Power Capital continues to be opportunistic in evaluating prospects across the renewable energy, bio-medical, pharmaceutical and naturopathic sectors, both as an investor and as an operator. The company’s main focus at the moment is to identify such opportunities in the renewable energy industry, including wind, solar and geothermal power and hydrogen and fuel cell technologies, as well as in the biomedical, pharmaceutical and naturopathic sectors, which may include medical or recreational cannabis.

Clean Power Capital currently has 10 investments in a variety of sectors and successfully held nearly C$120 million in investments during the past fiscal year (https://ibn.fm/8oktZ). It returned capital to its shareholders through the distribution of its interest in AgraFlora Organics International Inc. in May 2020 (https://ibn.fm/FRAvq).

Headquartered in Vancouver, British Columbia, Clean Power Capital was formerly named Organic Flower Investments Group Inc. As of November 10, 2020, the company officially changed its name to Clean Power Capital and started trading on the CSE under new ticker symbol ‘MOVE’.

PowerTap Acquisition, Hydrogen Fueling Infrastructure Collaboration

In alignment with its updated investment policy, a reconstituted investment committee and a revised strategy to reflect its focus on the renewable energy market, Clean Power Capital recently completed the acquisition of a 90 percent equity interest in California-based PowerTap Hydrogen Fueling Corp.

Leveraging an impressive portfolio of IP and advanced deployed technologies developed over two decades via substantial investments and partnerships, PowerTap is working on building and expanding a hydrogen filling station network, initially across North America. The company believes that its platform has a significant advantage over other hydrogen fueling stations, because it has a smaller physical footprint and further has the capacity to produce hydrogen fuel on site. As most other hydrogen fueling stations buy hydrogen for storage at higher costs, PowerTap’s model is believed to be exponentially more cost-effective and expandable.

Clean Power Capital’s investment and acquisition will allow PowerTap to step up its efforts and begin work on the hydrogen fueling station network in stages, starting with engineering and design, ongoing development of PowerTap’s third generation product and, finally, licensing & permitting and site preparation. Development is expected to begin in Q4 2021 with engineering and design. Overall, the initial portion of the project is expected to cost $17 million, with Clean Power Capital and PowerTap planning to secure government financing and credit, as well as equity, debt and convertible debt offerings, to fund the infrastructure’s development.

PowerTap technology is already deployed across multiple hydrogen fueling stations in public and private enterprises spanning California, Maryland, Massachusetts and Texas. The company plans to deploy its hydrogen fueling infrastructure at existing truck stops and gas stations across the country, beginning with up to 1,000 stations within the next three to five years. At the moment, there are roughly 70 active hydrogen fueling stations operational and available to consumers in the United States.

Hydrogen Industry Outlook

The project is expected to bring significant opportunities for PowerTap and Clean Power Capital on the fast-growing hydrogen market, driven by a worldwide focus on clean energies and environmentally friendly fueling solutions for the transportation industry.

Hydrogen-powered vehicles come with tremendous advantages over gas, diesel and even electric vehicles in terms of cost per mile, fueling time and driving range, as well as boasting significantly lower emissions. Well-established vehicle manufacturers such as Hyundai, Toyota, Daimler and Volvo are already including hydrogen-powered cars in their product lineups, and Nikola Motors has announced plans to manufacture hydrogen electric long-haul vehicles.

“As an experienced developer of technology in an important area that is finally having its time as a green but also economically compelling energy option, PowerTap is intent on becoming a leading part of the multi-billion dollar hydrogen fueling space,” PowerTap CEO Raghu Kilambi explained in a news release on October 28, 2020 (https://ibn.fm/oaXem).

A recent industry report developed by a coalition of major oil and gas, power, automotive, fuel cell and hydrogen companies indicates that the sector is expected to grow to $140 billion a year in revenue by 2030, creating 700,000 jobs in the U.S. alone (https://ibn.fm/UMI5q). According to Fuel Cell and Hydrogen Energy Association President Morry Markowitz, the sector could expand to $750 billion a year in revenue and 3.4 million jobs by 2050.

The U.S. is already engaged in the hydrogen economy, having more than half of the global number of fuel cell vehicles and investing hundreds of millions of dollars a year, but the country can greatly expand its global energy leadership by scaling up operations in the hydrogen economy, per the industry report.

With the upcoming change in administration in January 2021, the U.S. is expected to renew its commitment to clean energy. Moreover, the U.S. federal government is expected to invest significantly in clean energy and related infrastructure, including hydrogen, according to PowerTap.

“As the U.S. federal government has previously invested in the PowerTap technology, we are optimistic that we will have a seat at the table when USA clean energy/hydrogen infrastructure spending initiatives are designed,” Kilambi added.

Management Team

Joel Dumaresq is the CEO and interim CFO of Clean Power Capital. He is a proven executive with extensive operational and senior management experience in mining, energy and alternative energy, as well as the cannabis and hemp space. Dumaresq began his career in the corporate finance space, having spent 12 years with RBC Dominion Securities. He brings 30 years of experience in the financial sector to the company, has been instrumental in raising over $250 million in venture capital finance, and he has personally managed a number of successful public listings.

Brendan Purdy serves as a director of Clean Power Capital. An experienced businessperson who has led five different companies, Purdy brings years of experience in different industries, including cannabis, blockchain and data security, gaming, mining and energy, and finance and law. He received a graduate degree from the University of Ottawa and an undergraduate degree from the University of Western Ontario.

Theo van der Linde serves as a director of Clean Power Capital. He is a Chartered Accountant with over 20 years extensive experience in finance, reporting, regulatory requirements, public company administration, equity markets and financing of publicly traded companies. He has served as a CFO & Director for a number of TSX Venture Exchange- and Canadian Securities Exchange-listed companies over the past several years. His industry experience spans the financial services, manufacturing, oil & gas, mining and retail industries. More recently, van der Linde has been involved with future use trends of natural resources, as well as other disruptive technologies.

Raghu Kilambi is the CEO and CFO of PowerTap Hydrogen. He is a seasoned investor and entrepreneur with over 25 years of global business experience in public and private investments, building businesses and creating shareholder value. He has raised over $1 billion of equity and debt capital for private and public companies and been involved in many M&A acquisitions and exits.

Clean Power Capital Corp. (OTC: MOTNF), closed Wednesday's trading session at $1.6471, off by 7.2579%, on 255,043 volume with 317 trades. The average volume for the last 3 months is 221,910 and the stock's 52-week low/high is $0.0315/$2.78999996.

Recent News

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER)

The QualityStocks Daily Newsletter would like to spotlight The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER).

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products, announced that revenue for Q3 2021 reached $10.2 million an increase of $1.7 million year over year and a record for the company. The company also noted that earnings per share for Q3 2021, the period ending Dec. 31, 2020, were up 14.3% compared to the previous year and that the company’s Direct Store Delivery (“DSD”) had reached more than 10,000 customers, with its A888CBD(TM) line seeing its national distribution network increasing with KeHE, UNFI, BettermentRS and broker C.A. Fortune. To view the full press releases, visit http://ibn.fm/WIVjB and http://ibn.fm/zhsnB. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Two bills in Utah’s state legislature may bring change to the state’s medical marijuana program. Since the state’s voters passed a bill approving medical marijuana in 2018, the medical program has slowly started progressing. However, it has faced various challenges, which legislators have tried addressing through legislations.

Founded in 2012, The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88®, is a leading premier alkaline water brand available in bulk and single-serve sizes, along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88® delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts the company’s trademarked label ‘Clean Beverage’. Quickly being recognized as a growing lifestyle brand, Alkaline88® launched A88 Infused™ in 2019 to meet consumer demand for flavor-infused products. A88 Infused™ flavored water is available in six unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched the A88CBD™ brand, featuring a broad line of topical and ingestible products. These products are made with lab-tested full and broad-spectrum hemp and include salves, balms, lotions, essential oils, bath-salts, CBD infused drinks, tinctures, capsules, gummies and powder packs.

Innovation and Expansion

Founded in 2012, The Alkaline Water Company began with a mission to create the best-tasting water in the world. At the time, there were two emerging trends in health-conscious consumers: a growing interest in the alkaline diet and perceived health benefits of pink Himalayan rock salt. By combining these two concepts in an alkaline water and trademarking the name Alkaline88, The Alkaline Water Company began offering what it calls the smoothest tasting Clean Beverage™ in the U.S. enhanced-water category.

Now a top bulk alkaline-water brand (the company reported record sales in March and April 2020, surpassing March and April 2019 numbers by 114% and 171%, respectively), The Alkaline Water Company is committed to growing its national footprint through innovation and expansion. That mindset was evident as the company introduced eco-friendly aluminum bottles and branched out into flavor-infused waters; the company currently offers six different flavors: peach/mango, lemon/lime, raspberry, watermelon, blood orange and lemon.

The company’s commitment to innovation may be most evident in its newest product line: A88CBD. This line of CBD-infused products includes tinctures, capsules, gummies, salves, balms, hand and foot lotions, essential oils, bath bombs and bath salts, as well as CBD-infused drinks, water and beverage shots. These quality, CBD-infused offerings are all made with lab-tested, full-spectrum hemp and are conveniently packaged and perfect for on-the-go or at home use.

In addition, The Alkaline Water Company has implemented an aggressive growth strategy, with numerous organic initiatives focused on national multichannel, mass-market expansion through a direct-to-warehouse model and co-packing facilities that are strategically located within 600 miles of 95% of the U.S. population. In addition to this strong brick-and-mortar approach, the company recently launched a B2C e-commerce platform (www.A88CBD.com) and aggressive digital-marketing campaigns.

Clear Advantages in a Growing Market

With consistent growth year over year, the company reported $32.2 million in revenue in fiscal 2019 and has emerged as a growth leader in the functional (value-added) waters space, which is the fastest-growing segment of the bottled water industry.

The Alkaline Water Company’s efforts are focused on its clear competitive advantages, including its strong marketing (the inclusion of alkaline in product names); existing grocery channels, which feature excellent relationships and a nationwide broker network; distinctive branding; proprietary technology, which produces great-tasting, high-quality water, infused drinks and other products; and price, with a broad range of products in all formats, from bulk bottles to single serve.

As the company focuses on strategic growth, it is eyeing the impressive potential of a market that is on a strong upswing. Annual bottled water sales have now surpassed soda consumption, with soda sales in the United States having declined by $1.2 billion over the past five years. Some research indicates that the global bottled water market will reach an estimated $280 billion this year, while the CBD market is forecast to top $20 billion by 2024.

With its products available in all major trade channels, including grocery stores, drug stores, c-stores and big-box retailers, The Alkaline Water Company is also looking to expand into new spaces, such as health and beauty, hospitality and specialty retailer locations.

Seasoned Management Team

The Alkaline Water Company is led by an experienced team focused on the company’s core strategy of building a national retail footprint and extending its lifestyle brands into other consumer packaged goods categories.

Richard A. Wright, President, CEO and Co-Founder of The Alkaline Water Company Inc., oversees all aspects of the business, successfully guiding the company through strategic opportunities and delivering greater than 50% growth since the company’s inception. A passionate and versatile leader with a strong track record of innovation, collaboration and achieving goal-driven results, Wright is a serial entrepreneur with more than 41 years of experience. Early in his career, he spent years at one of the ‘Big Four’ accounting firms, working his way up to Regional Director of Tax and Financial Planning. As a CPA, entrepreneur and former CFO, Wright brings extensive knowledge of finance, operations, sales and marketing to the team, and he has participated in hundreds of M&A transactions throughout his career.

David Guarino, CFO, Secretary, Treasurer and Director, earned a Bachelor of Science in accounting and a Master of Accountancy from the University of Denver. From 2008 to 2013, Guarino was President and a Director of Kahala Corp., a worldwide franchisor of multiple quick-service restaurant brands with locations in 49 states and more than 25 countries. From 2014 to 2015, Guarino was President of HTI International Holdings Inc., a technology company focused on forward osmosis water filtration technology.

Frank Chessman, National Sales Manager, is a graduate of the University of Southern California’s Marshall School of Business. He spent 25 years with Ralph’s Grocery, Kroger’s largest division, working at many levels before ultimately becoming Vice President of Advertising & Marketing. He then served 14 years as Executive Vice President at Simon Marketing. Chessman has more than a decade of experience in the beverage manufacturing industry.

Brian Sudano, Director, is managing partner of Beverage Marketing Corporation and BMC Strategic Associates. Sudano’s experience covers nearly the entire beverage industry, from energy drinks to wine, with special expertise in beverage alcohol by virtue of varied industry experience across a broad range of projects. Sudano manages several major clients, providing ongoing strategic and market advice and leading projects in strategic planning, market entry analysis and planning, sales/distribution, business modeling, brand repositioning and international opportunity assessment. He has spoken at many beverage industry events and is a contributing editor at Beverage World magazine.

Aaron Keay, Chairman, has been a successful investor, entrepreneur and financier to multiple small cap and startup companies over the last decade. During his time with these companies, he served in advisor, board-member and senior-management roles. His experience ranges across multiple sectors in mining, biotech, health and wellness, tech and cannabis, where he has invested and raised more than $500 million.

The Alkaline Water Company Inc. (NASDAQ: WTER), closed Wednesday's trading session at $1.35, off by 5.2632%, on 5,109,261 volume with 12,510 trades. The average volume for the last 3 months is 2,320,327 and the stock's 52-week low/high is $0.400000005/$2.5999999.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

closed Monday's trading